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In response to evidence of an increasing disconnect between financial 
reporting and firm value, a number of commentators have called upon firms to 
expand their disclosures of intangibles information, particularly disclosures of 
non-financial measures.  In this study, I use an experiment to examine whether 
and when expanded disclosures of non-financial intangibles information affect 
investor judgments of financial performance.  I propose that, given the complexity 
of the relationships between today’s intangibles activities and future financial 
results, investors may fail to retain and/or use the information contained in non-
financial intangibles disclosures, and performance on non-financial measures may 
not be reflected in their judgments of future financial performance. Certain 
investors, those who have high familiarity with the industry setting, should have 
well-developed causal models that allow them to use the non-financial measures 
 viii 
and relate them to judgments of future financial performance.  On the other hand, 
investors who have low familiarity with the industry setting may not have well-
developed causal models, so that expanded disclosure of non-financial 
information may not be sufficient to influence these investors’ judgments.  
Instead, these investors may need to receive supplemental discussion of how a 
firm’s non-financial measures are causally linked to future financial performance 
in order to use the non-financial information.   
Experimental results for the full sample, combining high familiarity and 
low familiarity investors, are mixed, and are related to which performance 
measure is used as the dependent variable.  I also examine the results for the 
subset of investors with relatively low familiarity with the industry setting used in 
the study.  For these investors, disclosure of non-financial measures alone is not 
sufficient to influence their performance judgments, and non-financial measures 
are incorporated into performance judgments only when the supplemental causal 
links discussion is provided.  Additional analysis suggests that these results for 
the low familiarity investors are due to supplemental causal links discussion 
affecting the use of non-financial information in investors’ performance 
judgments, and are not due to causal links discussion affecting retention of non-
financial information.  This study provides evidence on the effects on investor 
judgments from expanded intangibles disclosures and the necessary conditions for 
achieving such effects. 
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Chapter 1: Introduction 
The ability of accounting and financial reporting data to represent and 
report information that is useful in assessing firm value and management 
performance has come under a great deal of scrutiny in recent years.  Evidence 
exists that an increasing number of items that affect valuation are not captured in 
firms’ financial statements.  This disconnect is particularly acute for firms with 
large, unrecognized, investments in intangible assets.  Critics suggest that firms 
should compensate for this by expanding their disclosures of intangibles 
information, particularly disclosures of non-financial measures1 (Lev, 2001, and 
Eccles, Herz, Keegan, and Phillips, 2001, Financial Accounting Standards Board, 
2002).  Their rationale is that these expanded disclosures will better communicate 
a company’s economics and help unlock additional relevant information about 
firm value.  This will allow investors to distinguish between strong and weak 
firms, resulting in more differentiated investment-related judgments. 
The realization of these benefits relies on the assumption that investors 
will react to and use the expanded intangibles information in their judgments.  
Whether and when this happens is unclear.  It is possible that simply providing 
                                                 
1 Intangible assets are defined by the Financial Accounting Standards Board as assets (not 
including financial assets) that lack physical substance (FASB, 2001).  Although intangible assets 
are associated with firm value in the financial markets, only certain intangible assets (mostly 
purchased intangible assets) are recognized for accounting purposes.  To mitigate the lack of 
recognition of intangible assets, firms are being encouraged to expand disclosure of information 
about intangible assets. Disclosures of non-financial measures, defined as non-monetized, 
operational data, provide information about various dimensions of a firm’s (recognized and 
unrecognized) intangible assets and thus are seen as an avenue for providing additional 
information to investors about a firm’s intangible assets and firm value.  In this study, I examine 
investor reactions to disclosures of non-financial measures, with an eye toward the broader 
discussion of disclosures of information about intangible assets.      
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non-financial intangibles information will lead to investors incorporating this 
information in their judgments.  On the other hand, the relationships between 
today’s intangibles activity and the related non-financial measures and future 
financial results can be complex.  If complex relations are misunderstood, 
mischaracterized, or even ignored, expanded disclosures of non-financial 
intangibles information may not have the effect on investors that their advocates 
envision.  That is, disclosure alone of non-financial information might not affect 
investors’ judgments, because investors lack the knowledge to retain and use the 
information.  
In an experiment set in a research and development investment context, I 
study whether and when expanded disclosure of non-financial intangibles 
information leads to different investor judgments.  I use a 2 X 2 plus 1 between 
subjects research design.  The first factor that I manipulate is causal links 
discussion.  Participants who receive a report on non-financial measures either 
receive it with or without a supplemental discussion of how the firm’s non-
financial intangibles measures are causally linked to future financial performance.  
The provision of cause-and-effect links is intended to clarify the complex 
relationships between non-financial measures and future performance, thus 
leading to increased use of non-financial intangibles disclosures in investor 
judgments, relative to disclosure of non-financial measures alone.  The second 
manipulated factor is level of non-financial performance, where the disclosing 
firm is identified as having either above or below-average performance on non-
financial measures.  The performance manipulation is used to examine whether 
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and when investors differentiate between high and low performing firms by 
incorporating the content of non-financial intangibles disclosures in their 
judgments.  The “plus 1” is a control condition where participants receive neither 
the report on non-financial measures nor the links discussion.   
I hypothesize that, due to a lack of knowledge about the complex 
relationships between non-financial measures and future financial performance, 
disclosure of non-financial intangibles information without causal links discussion 
is less likely to affect investors’ future financial performance judgments.  In other 
words, in the absence of links discussion, investors’ performance judgments in the 
above-average and below-average conditions are less differentiated from each 
other, and less differentiated from judgments in the control (baseline) condition, 
where non-financial measures are not provided.  When the causal links discussion 
is provided, I hypothesize that investors are more likely to incorporate non-
financial measures into their judgments of future performance.  This results in the 
prediction of a causal links discussion by performance level interaction, where 
investors more strongly differentiate between the above and below-average firms 
in their judgments when a links discussion is provided.   
One complicating factor related to these hypotheses is the presence of high 
familiarity (high knowledge) investors who may already possess well-developed 
causal models that allow them to use the non-financial measures when disclosed 
alone.  If the causal models possessed by these high familiarity investors match 
the causal model implied by the supplemental causal links discussion, then the 
provision of cause-and-effect links would not affect these investors’ performance 
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judgments.   Accordingly, I partition the data on the basis of industry familiarity, 
and analyze results for the full sample, for a subset of investors with self-reported 
high familiarity with the industry setting, and for a subset of investors with self-
reported low familiarity with the industry setting. 
For the full sample, I find mixed results with respect to my predictions, 
depending on which performance measure is used as the dependent variable.  For 
next period revenue estimates, investors’ estimates for above-average and below-
average firms are not significantly different in the absence of the causal links 
discussion, and they are significantly different when the links discussion is 
provided, as hypothesized.  For judgments of future revenue growth (3 to 5 years 
out), there is significant differentiation without the causal links discussion, 
contrary to predictions.  Additionally, providing the links discussion does not 
increase the differentiation between above-average and below-average firms, also 
contrary to predictions.   
I then examine the results for the subset of investors who self-identified as 
having lower familiarity with the industry setting used in the experimental 
materials.  Unlike high familiarity investors who may be able to process non-
financial measures when disclosed alone, low familiarity investors may not have 
well-developed causal models, so that expanded disclosure alone of non-financial 
measures may not be sufficient to influence these investors’ judgments.  Instead, 
these investors may need to receive the supplemental links discussion.  Results for 
these low familiarity investors indicate that disclosure of non-financial measures 
alone is not sufficient to influence their performance judgments, as their 
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assessments of the above-average and below-average firms are not significantly 
different in the absence of links, as hypothesized.  When the links discussion is 
provided, non-financial measures are incorporated in performance judgments, as 
hypothesized.   
Data for the subset of investors who self-identified as having higher 
familiarity with the industry setting were also examined.  However the small 
number of investors classified as high familiarity precludes me from making any 
meaningful conclusions about this group. 
Overall, these results suggest that having causal models about non-
financial measures and their relationships with future financial performance 
measures helps investors use non-financial measures.  Furthermore, investors who 
do not already possess these models (from their industry familiarity) can 
“acquire” a model when cause-and-effect linkages are provided.  Additionally, the 
results show that disclosure alone of non-financial intangibles information may 
not be sufficient to influence low familiarity investors’ judgments.   
This study is of interest to managers of firms (in particular CFOs and 
investor relations staff of intangibles-heavy firms), accounting researchers, and 
standard setters.  Managers have expressed an interest in increasing the 
transparency of their disclosures to better communicate information about firm 
value to investors (Eccles et al, 2001).  Information about investors’ reactions to 
and use of intangibles information can help managers identify when their 
disclosures are most effective, and help them achieve their goal of better 
communication.   
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Additionally, non-financial information is an emerging area of accounting 
research and I provide evidence on the role of supplemental causal link 
disclosures and industry familiarity on investors’ use of non-financial 
performance information.  The experimental method is well-suited for this study.  
Conducting my study in a laboratory setting allows me to control for incentives 
and self-selection of disclosures, which would not be possible using archival data 
(Libby, Bloomfield, and Nelson, 2002).  This study is also in contrast to prior 
behavioral financial accounting studies that examine historical financial 
information and its influence on judgments of future financial performance, and 
ultimately on investor valuation judgments (e.g. Hirst and Hopkins (1998), 
Maines and McDaniel (2000), Krische (2001), Hirst, Jackson, and Koonce (2003), 
and Frederickson and Miller (2004)).  I examine how historical non-financial 
measures influence perceptions of future financial performance.  Given that these 
amounts are non-financial and the relationships to future financial performance 
are complex, it is not clear ex ante how they will be mapped into judgments of 
future financial performance by investors.  This study examines whether and 
when disclosure alone is sufficient to influence investor judgments, and whether 
and when supplemental causal links discussion is necessary. 
Finally, the FASB has identified expanded disclosures of information 
about intangible assets as one of its areas of interest and I provide evidence on the 
variables that influence investors’ use of non-financial intangibles information.  
The remainder of this dissertation is organized as follows: Chapter 2 
discusses the complexities of forecasting performance in the presence of research 
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and development investment.  Chapter 3 presents a model of investor processing 
of non-financial intangibles information and develops the hypotheses.  Chapter 4 
discusses the research method.  Chapter 5 presents the results and Chapter 6 
summarizes the findings and concludes. 
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Chapter 2: Forecasting in a Research and Development 
Investment Setting 
2.1  DIFFICULTIES IN FORECASTING IN A RESEARCH AND DEVELOPMENT 
INVESTMENT SETTING 
Evidence exists that a number of items affecting valuation are not captured 
in firms’ financial statements (e.g. Amir and Lev, 1996, Lev and Sougiannis, 
1996).2  This disconnect is particularly acute for firms with large, unrecognized, 
investments in intangible assets (Lev, 2001). For investors in these firms, this 
makes the task of forecasting future financial performance much more 
challenging. 
For example, for a pharmaceutical company in the midst of a research and 
development (R&D) initiative, the company may be reporting significant revenue 
growth, but it may also report much smaller increases in earnings, due to its R&D 
expense.  Given this scenario, how does an investor forecast future financial 
performance?  First, forecasting earnings may be very difficult, because of the 
uncertainties surrounding the persistence of discretionary R&D expense.  
                                                 
2 Many of these items are related to companies’ investments in information and technology.  With 
the evolution of the economy in recent years to a more information-based economy, the magnitude 
and prominence of these uncaptured items has increased, leading some to claim that the value-
relevance of financial statements is declining (Lev, 2000).  Other researchers disagree that there 
has been a decline in the value-relevance of financial statements.  Collins, Maydew, and Weiss 
(1997) and Francis and Schipper (1999) find little evidence that the overall value relevance of 
financial statements has declined over time.  Similarly, Core, Guay, and Van Buskirk (2003) find 
little evidence of a change in the determinants of equity values over a 25 year period ending in 
2000.  While the debate on the value relevance of financial statements remains unsettled, the fact 
remains that standard setters and financial statement preparers have been spurred on to take action.  




Although forecasting revenue may be incrementally easier than forecasting 
earnings because it is not directly affected by current R&D expense, the timing of 
future revenue could be significantly affected by the fruits of the current R&D 
initiative. 
Prior archival-empirical research suggests that current required disclosures 
of R&D expense may be useful to investors in R&D intensive firms.  Lev and 
Sougiannis (1996) find that the valuation of R&D intensive firms is more 
consistent with “adjusted GAAP” earnings (R&D expenditures added back and 
amortized) than GAAP earnings (immediate expensing of R&D expenditures).  
These results suggest that investors in R&D intensive firms make an adjustment 
for R&D expense in their valuations.  However, disclosures of R&D expense, 
while useful for approximating future benefits from R&D investment, are coarse 
estimates of those benefits.  They reflect inputs into the R&D process, not 
outputs.  For example, two firms with the same amount of R&D spending could 
have very different future financial prospects due to their different respective 
returns on R&D investment.  Disclosures of R&D expense alone would not be 
able to help investors differentiate between these two firms.   
2.2 DISCLOSURE OF NON-FINANCIAL MEASURES 
To supplement the information about intangible assets contained in 
disclosures of R&D expense, Lev (2001) and Eccles et al (2001) call upon 
companies to expand and improve the disclosures of intangibles information in 
financial reports, particularly non-financial information about a company’s 
activity and progress in the various stages of the intangibles/innovation process.  
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These disclosures of non-financial measures, especially those that are leading 
indicators of intangibles process outputs, provide information on additional 
dimensions of firm performance that are not captured in disclosures of R&D 
expense.  Disclosures of R&D spending with non-financial measures are arguably 
more useful than disclosures of R&D spending alone because non-financial 
measures report on the firm’s activity and progress in later stages of the 
innovation process, when the effects on future financial performance are more 
imminent.  In the case of the two firms with equal amounts of R&D investment, 
any differences in their internal returns on R&D investment would be reflected in 
their performance on non-financial measures (for example, above-average vs. 
below-average patent generation).  Investors who are provided with non-financial 
intangibles disclosures would then be able to better differentiate between these 
firms. 
If non-financial measures provide information about the amount and 
timing of future benefits from the current R&D initiative, investors should be able 
to differentiate between firms on the basis of the effectiveness of their R&D 
activities.  This differentiation should then be reflected in investors’ forecasts of 
revenue (and revenue growth).  However, the effect of disclosing non-financial 
measures on investors’ forecasts of earnings (and earnings growth) is less 
straightforward, because of the unknown nature of the future R&D spending 
strategy of the firm. 
This discussion illustrates how expanded disclosures of non-financial 
measures can facilitate forecasting for R&D intensive firms.  However, it is not 
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clear that simply expanding disclosures of non-financial measures will be 
sufficient to affect investors’ performance judgments and forecasts for R&D 
intensive firms.  The relationships between non-financial measures and future 
financial results may be sufficiently complex (mostly due to lagged effects), such 
that investors could observe performance on non-financial measures (in the 
expanded disclosures), but not reflect that performance in their subsequent 
investment-related judgments.  Indeed, Upton (2001) observes that “Many 
nonfinancial metrics…are unfamiliar to users of business information,” 
suggesting that expanded disclosures may be too complex for investors to 
understand.  In the next chapter, I introduce a model of investor processing of 
non-financial intangibles information that predicts whether and when the 
information contained in non-financial measures is incorporated in investors’ 
performance judgments. 
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Chapter 3: Investor Processing of Non-Financial Intangibles 
Information 
3.1 CHAPTER OVERVIEW 
In Chapter 2, expanded disclosure of non-financial intangibles information 
was proposed to reduce the information gap for investors in R&D intensive firms.  
In this chapter, I present a model of investor3 processing of non-financial 
intangibles information to predict whether and when investors incorporate the 
information contained in disclosures of non-financial intangibles information in 
their performance judgments.   
In a study examining investors’ processing of comprehensive income 
information, Maines and McDaniel (2000) propose a framework suggesting that 
disclosed information moves through three processing stages, information 
acquisition (which includes information retention), information evaluation, and 
information weighting, prior to being incorporated into investors’ judgments of 
performance.  Furthermore, Maines and McDaniel propose that disclosure-related 
variables (presentation format in the case of their comprehensive income study) 
could influence investors’ performance judgments, through their effect on any or 
all of the processing stages that precede the overall performance judgment. 
                                                 
3 Because disclosure of non-financial information supports financial analysis, it can be argued that 
the intended primary recipients for these disclosures are information intermediaries (i.e. financial 
analysts), and that (individual) investors use this information only after it has been processed by 
information intermediaries.  However, a non-trivial number of firms have no analyst following 
(Chambers, Jennings, and Thompson, 2004, find that 38% of earnings reports during the period 
1984-2002 have zero associated analyst forecasts).  For these firms with no analyst following, 
information about non-financial measures goes directly to the investor, so examination of investor 
reactions to disclosures of non-financial information is warranted. 
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In this study, I employ a framework that is similar to the one used by 
Maines and McDaniel (2000).  I propose that investors’ processing of non-
financial intangibles information moves through the stages of information 
retention and information weighting prior to being incorporated in performance 
judgments, and whether the non-financial intangibles information is incorporated 
in investors’ performance judgments is a function of investors’ retention and 


















































































































































































































   










   






























































































   

























































































































































































































As indicated in Figure 1, investors who are presented with expanded 
disclosures of non-financial measures must retain that information (“YES” at 
Node A) and must weight/use that information (“YES” at Node B) in order for 
the performance-relevant information contained in the non-financial measures 
to be reflected in their performance judgments.   
The processing of non-financial measures by investors and their 
translation into judgments of future financial performance is made more 
complex by certain key features of non-financial measures.  First, because non-
financial measures are specific to each particular company’s operations, 
disclosures thereof vary from company to company, resulting in inconsistent 
presentation across companies.  Non-financial measures are disclosed in 
different locations in financial reports, and are disclosed in different 
combinations depending upon the company.  Additionally, the labels and 
definitions for non-financial measures vary from company to company.  
Second, non-financial measures are not monetized so there will be some effort 
required to translate performance on non-financial measures to the appropriate 
magnitude of effect in financial terms.  Finally, non-financial measures often 
have lagged effects on future financial performance (Jackson, 2004), so the 
magnitude of effect determined earlier would need to be assigned to particular 
future periods.  Because of these unique features, processing of non-financial 
measures and translating them into judgments of future financial performance is 
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a complex task, as it requires the integration of multiple inputs and outputs on 
the part of the investor.4     
What would positively influence an investor’s ability to retain and use 
non-financial intangibles information and to translate this information into 
judgments of future financial performance?  It would seem that having a well-
developed causal model would help investors process non-financial intangibles 
information.  Investors with a well-developed causal model would have a 
framework for receiving information about non-financial measures, to 
counteract the lack of standardization of non-financial disclosures.  In addition, 
investors with a well-developed causal model would have a better 
understanding of how inputs and outputs of the forecasting process are related, 
to counteract the non-monetized and lagged effect features of non-financial 
measures.   
This leads to the next question—what factors lead to investors having 
well-developed causal models?  Libby and Luft (1993) posit that judgment 
performance in accounting settings is a function of ability, knowledge, 
environment, and motivation.5  Accordingly, characteristics of the decision-
maker and characteristics of the task/environment can both potentially influence 
the outcomes on a task.  Applying the Libby and Luft (1993) model to the 
current study, I propose that a well-developed causal model can be the result of 
                                                 
4 Bonner’s (1994) model of audit task complexity suggests that task complexity is a function of 
the complexity (the amount and clarity) of inputs, processing, and outputs related to the task. 
5 Libby and Luft’s (1993) model proposes that the four factors above (ability, knowledge, 
environment, and motivation) affect processing, which in turn affects “judgment performance” 
(the conceptual dependent variable).  In this study, I am not examining judgment performance, 
per se, because I do not have a normative benchmark against which to measure performance.  
However, the Libby and Luft (1993) model is still applicable, because I am interested in how 
the four factors (or a subset of the four factors) affect processing.    
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characteristics of the investor (investor familiarity6 with the industry) or 
characteristics of the environment (a decision aid, such as a causal links 
discussion).  Ultimately, the presence of a well-developed causal model on the 
part of the investor affects whether they retain (“YES” at Node A) and use 
(“YES” at Node B) information on non-financial measures in their performance 
judgments. 
3.2  THE ROLE OF FAMILIARITY ON INVESTOR PROCESSING OF NON-
FINANCIAL INTANGIBLES INFORMATION 
Earlier, I suggested that the complex relationships between non-
financial measures and future financial results could lead to NFM performance 
not being reflected in investors’ judgments of future financial performance. 
Investors who have familiarity with the industry setting are less likely to be 
susceptible to this complexity, because they are familiar with the non-financial 
measures that are the relevant inputs to an investment decision.  An investor 
who is familiar with the industry setting is also more familiar with the value-
generating process in the industry, and how non-financial inputs are translated 
into future financial performance in terms of magnitude and timing (i.e. they 
are more likely to have well-developed causal models).  Accordingly, an 
investor who is familiar with the industry setting is expected to retain and use 
information contained in disclosures of non-financial measures if the 
information is disclosed, even if a supplemental causal links discussion is not 
                                                 
6 It is important to note that, in this study, I partition investors on the basis of (self-reported) 
familiarity with the industry setting, rather than on the basis of knowledge.  Although 
knowledge and familiarity with the industry are not the same concept, the factors that contribute 
to familiarity with the industry (work experience, exposure through school projects) also 
contribute to knowledge.  Accordingly, the selection of familiarity as the variable of interest in 
this study is consistent with the Libby and Luft (1993) framework. 
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provided.  That is, a causal links discussion may be redundant with pre-existing 
high familiarity.  Following this, an investor with high familiarity with the 
industry setting would incorporate more of the performance information 
contained in the non-financial measures in subsequent performance judgments, 
with disclosure alone.   
3.3  THE ROLE OF ENVIRONMENT (CAUSAL LINKS DISCUSSION) ON 
INVESTOR PROCESSING OF NON-FINANCIAL INTANGIBLES INFORMATION 
Investors with low familiarity with the industry setting bring little to no 
knowledge of the industry to the forecasting task, so they could have difficulty 
processing non-financial measures in the face of the complex relationships 
between non-financial measures and future financial performance.  However, 
there are aspects of the task environment that can be modified to provide causal 
models for these investors and to increase the incorporation of non-financial 
measures in their performance judgments.  One such modification is to provide 
investors with supplemental information, causally linking non-financial 
measures to future financial performance (the causal links discussion). A look 
at firms’ financial reports suggests that some firms are attempting to provide 
such linkages in their communications with investors.  In its 1999 annual report 
Axcan Pharma reported: 
“Our aim for the next five years is to have one product or new 
indication from our research program approved each year in the United 
States……Axcan is conducting a double-blind study…in Canada and 
the United States.  Once the study is completed in 2001, we will seek 
regulatory approval to promote URSOR 250 mg as an effective treatment 
for this disease in the United States.  We foresee approval for this 
treatment by 2004, with potential revenues of US $150 million.” 
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The Axcan disclosure links the innovation activity with the expected 
time to market and the potential future revenues, providing causal linkages of 
non-financial measures to future financial performance.  However, linkage 
disclosures are not made by all companies on a consistent basis (Upton 2001), 
suggesting that there is some disagreement over the effectiveness of such 
disclosures.  
Prior research in psychology suggests that information that is causally 
linked to a judgment variable tends to be attended to and used more.  Einhorn 
and Hogarth (1986), Tversky and Kahneman (1980), and Ajzen (1977) argue 
that this is the case because individuals tend to organize events in terms of 
cause-and-effect relations.  Indeed, in an early study in accounting that 
examines causal relations and auditor judgments, Kida (1984) finds that 
auditors’ return on investment (ROI) assessments are more associated with cues 
that are causally linked to ROI than with cues that are not causally linked.   
In Kida’s (1984) study, the cues were inherently linked to ROI, and no 
explicit disclosure was made to enhance the perception of the causal link.  
However, there is evidence that supplemental explicit disclosure, providing 
information about causal relationships between variables, leads to a greater 
perceived relationship between the variables, especially if the inherent causal 
links are more obscure.  In a recent illustration of this concept, Kim and Ahn 
(2002) provide individuals with symptoms of novel mental illnesses and vary 
whether symptoms are (1) deeper causes of other symptoms, (2) intermediate 
effects AND causes of other symptoms, (3) terminal effects, or (4) are causally 
unrelated to other symptoms.  They find that causally unrelated symptoms are 
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given less weight in category membership (diagnosis) decisions.  In other 
words, the disclosure affected the causal models developed by the individuals, 
which affected their subsequent judgments.   
The examination of links in the present study is related to a number of 
recent experimental accounting studies that examine the transparency of 
financial information and its use in investor performance judgments.  In these 
studies, the transparency of financial information is related to the degree to 
which it is linked to financial performance measures, with variables such as 
labeling, location, and inclusion in a performance measure affecting the degree 
of investors’ perceived linkage.   
Maines and McDaniel (2000) find that presentation format affects non-
professional investors’ weighting of comprehensive income information, which 
then flows through to subsequent investor judgments.  Maines and McDaniel 
(2000) attribute their results in part to presentation format signaling to investors 
how relevant comprehensive income is to evaluating the company’s 
performance.  When comprehensive income information is presented in the 
income statement, the link between comprehensive income and firm 
performance is at the highest level, through the location, labeling, and linkage 
to net income associated with this format.  When comprehensive income 
information is presented in the footnotes, the link between comprehensive 
income and firm performance is at the lowest level.  Maines and McDaniel 
(2000) find that weighting of comprehensive income information is highest 
when the link between comprehensive income and firm performance is the 
highest. 
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Hirst et al (2003) find similar results in an experimental study of 
investors’ reactions to disclosures of re-stated capitalized software costs.  
Specifically, they find that the most effective disclosure, where investors 
identified and corrected aggressive accounting estimates, explicitly described 
the implications of misestimation on both the balance sheet and on earnings 
(performance).  Disclosures that only addressed the balance sheet implications 
of misestimation were not as effective.  Similar to Maines and McDaniel 
(2000), the results of that study are consistent with the idea that linking 
disclosures to performance implications enhances the likelihood that the 
disclosed information will be incorporated into investors’ performance 
judgments. 
Other results in recent behavioral financial accounting research are 
consistent with this conjecture as well. In a setting with one-time prior period 
gains and losses, Krische (2001) finds a difference in investor judgments 
depending on how the (prior-period) benchmark is computed.  Her findings 
suggest that investors receive a signal about how to treat prior period gains and 
losses, based on whether the prior period gain or loss is excluded from the 
benchmark.  Similarly, Frederickson and Miller (2004) find that for non-
professional investors, whether pro-forma reconciling items are included in a 
summary performance measure influences subsequent investor judgments.  In 
both of these studies, investors receive a signal about how relevant a particular 
item is for valuation (in these two cases, linked by their inclusion in a 
performance measure), which affects how they treat the item in their investment 
judgments, consistent with the idea that links increase the relevance of a 
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disclosed measure for performance implications, which in turn increases the 
weight placed on that item in judgments of performance. 
Note that most prior research in accounting that looks at the salience of 
links between a disclosed item and firm performance has focused on disclosures 
of financial items (comprehensive income, aggressive software capitalization, 
one-time gains/losses, pro-forma reconciling items).  In this study, I examine 
the effect of providing a links discussion that makes the connection between a 
non-financial disclosure and future financial performance more salient.  In the 
next section, I provide additional background information about causal links 
discussion and non-financial measures.   
3.4 CAUSAL LINKS DISCUSSION AND NON-FINANCIAL MEASURES 
In recent years, a popular topic in the managerial accounting literature 
has been the importance of incorporating non-financial measures into 
performance measurement (Kaplan and Norton, 1992, 1993, 1996a, 1996b).  
One of the most discussed tools is the Balanced Scorecard, introduced by 
Kaplan and Norton (1992).  The Balanced Scorecard specifies cause-and-effect 
paths linking financial and non-financial measures to the company’s overall 
goal.  It is hypothesized to be more effective than previous systems in 
facilitating managers’ decisions (Kaplan and Norton, 2001) because providing 
linkages leads to managers internalizing non-financial measures more 
appropriately (Rucci, Kirn, and Quinn, 1998).  In this study, I examine whether 
providing cause-and-effect linkages could also affect investors’ incorporation 
of intangibles-related non-financial measures in their investment judgments. 
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While there are a number of studies suggesting that linking financial 
variables to performance indicators leads to those financial variables being 
incorporated in investor judgments, there is much less research involving causal 
links, non-financial information, and investor judgments.  One exception to this 
is a study by Sedor (2002), who posits that financial analysts organize and 
reason using cause-and-effect relations.  She varies the salience of the links 
between current period management initiatives (non-financial) and future 
financial outcomes, and finds that management’s initiatives are more heavily 
weighted in analysts’ judgments of future financial performance (leading to 
more optimistic judgments) when the links are more salient. Another exception 
examining financial and non-financial cues and auditor judgments is Earley 
(2001).  In a real estate valuation task, she finds that novice auditors who are 
provided with explanation feedback when learning, consisting of patterns of 
information used and relations among cues (similar to the causal links 
discussion in this study) make more accurate judgments in subsequent post-
tests.7   
                                                 
7 In another part of her study, Earley (2001) looks at the interplay between knowledge and 
explanatory feedback.  She finds that explanatory feedback does not improve the judgments of 
auditors who have a “high reasoning” level (i.e. those auditors who made links between items 
of information and/or related the items to each other in terms of an overall pattern or story).  
For those auditors who made links already, receiving information about cue relationships does 
not improve their judgments, suggesting that having knowledge ex ante and receiving causal 
links discussion are substitutes.   Earley’s (2001) observations about auditors with a high 
reasoning level are consistent with findings in psychology that individuals with extensive 
domain experience are more likely to reason using causal models (Lopez et al, 1997).    
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Primary (Performance-Related) Hypotheses related to Causal Links 
Discussion 
Figure 1 indicates that even if non-financial information is disclosed, 
there are pitfalls at nodes along the way, where investors who lack well-
developed causal models about non-financial measures and their relationships 
with financial measures could diverge from the path, and end up with a 
performance judgment that does not reflect performance on non-financial 
measures.   
This could be due to problems with information retention, where 
investors lack a framework to effectively encode non-financial information in 
memory (“NO” at Node A).  Separately, investors may encounter non-financial 
intangibles information and retain that information in memory, but because the 
implications for earnings are not clear (the framework is poorly developed), 
investors do not use/weight this information, so that it is not reflected in their 
performance judgments (“NO” at Node B).  Either of these scenarios could lead 
to newly disclosed non-financial information (if disclosed alone) not being 
incorporated in investors’ performance judgments. 
On the other hand, when investors have well-developed causal models 
(from either pre-existing familiarity or causal links discussion), causal 
reasoning is aided, and they are able to retain and use the information contained 
in non-financial measures and reflect it in subsequent investment judgments.   
  Based on the discussion in the preceding sections, I hypothesize that 
non-financial measures will not be incorporated into low familiarity investors’ 
performance judgments when there is no causal links discussion and will be 
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incorporated into investors’ performance judgments when there is links 
discussion or high familiarity.  As discussed earlier, disclosures of non-
financial intangibles information will reveal firms to either be performing 
above or below-average on their non-financial measures.  I hypothesize that 
low familiarity investors’ judgments will reflect less differentiation between the 
above and below-average firms when causal links discussion is not provided 
and will reflect more differentiation when causal links discussion is provided.  
These hypotheses are formalized as follows: 
H1: Low familiarity investors’ performance judgments will not reflect 
information contained in disclosures of non-financial intangibles 
information, and will not differentiate between above-average, below-
average, and non-disclosing (control/baseline condition) firms, with 
disclosure alone.   
H2: The information contained in disclosures of non-financial 
intangibles information will affect low familiarity investors’ 
performance judgments more when causal links discussion is provided 
than when it is not provided. 
Although hypotheses 1 and 2 are directed toward low familiarity 
investors, these hypotheses will also be tested using the full sample of high and 
low familiarity investors. 
See Figure 2 for a pictorial summary of the primary hypotheses.   
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FIGURE 2 - Pictorial Summary of Hypotheses 1 and 2 
DV= Revenue/Revenue Growth 
 







  (H1)   (H2) 
 
 
Hypothesis 2 predicts a difference between above-average and below-
average firms when causal links are provided.  I do not make a formal 
prediction about how judgments in these two links conditions compare to 
judgments in the control/baseline (no disclosure) condition.  Verrecchia (1983) 
observes that in the absence of proprietary costs of voluntary disclosure, 
rational expectations traders will infer bad news as soon as it becomes apparent 
that information is being withheld.  Thus, in this study, if there is no disclosure, 
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investors may infer low performance.  On the other hand, investors may have 
no ex ante expectation of disclosure (i.e. no belief that something is being 
withheld), as I believe is the case in this study.  I believe this because 
disclosures are not standardized and vary from company to company, so 
expectations are not formed.  Thus investors would not infer low performance 
from non-disclosure, but would instead infer an average level of performance.  
If this is the case, then judgments would be lower for the below-average links 
discussion firm, as compared to the non-disclosing (perceived to be average) 
firm.  Similarly, for hypothesis 1, I assume that investors have no ex ante 
expectation of disclosure, so their performance judgments are based on the 
content (if provided) of the NFM disclosures. 
Hypotheses Related to Process and Intermediate Stage Cognitions 
I am also interested in identifying the process/path through which any 
observed effect of causal links discussion on investors’ performance judgments 
occurs.  The supplemental links discussion is hypothesized to assist investors in 
developing a causal model related to non-financial measures.  The existence of 
a causal model is hypothesized to have two effects.  One is to provide a 
framework for the investor, similar to that of an advance organizer, initially 
researched by Ausubel (1968).  Ausubel (1968) defines advance organizers as 
“appropriately relevant and inclusive introductory materials…introduced in 
advance of learning and presented at a higher level of abstraction, generality, 
and inclusiveness” (p.148).   
In other advance organizer research, Mayer, Dyck, and Cook (1984) 
examine whether other advance organizer techniques assist in the development 
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of frameworks and mental models and enhance recall.  Mayer et al (1984) 
examine the effect of providing definitions of key terms of a cause-and-effect 
system.  They find that providing definitions enhances recall and enhances 
problem-solving performance.  More related to the present study, Mayer et al 
(1984) also examine whether signaling the key causal links of the cause-and-
effect system affects recall.  They find that signaling the key causal links also 
enhances recall and enhances problem-solving performance. 
The insights gained from prior psychology research on advance 
organizers are applicable to the present study of causal links discussion and 
non-financial intangibles disclosures.  The causal links discussion illustrates 
how the firm’s non-financial measures are linked to future financial 
performance.  If investors are provided with cause-and-effect links, they have 
an existing structure with which to receive new non-financial intangibles 
information.  With this structure in place, more associations between non-
financial measures and the existing structure are made, and the associations that 
are made are more salient and are retained better, because the future financial 
effects of today’s non-financial measures can be envisioned.  If causal links 
discussion affects information retention as hypothesized, differences in 
investors’ retention of non-financial intangibles information should be reflected 
their recall of non-financial information.  Accordingly, I propose the following 
process hypothesis: 
H3: Recall of performance on non-financial measures will be higher for 
investors who receive the causal links discussion than for investors who 
do not receive it. 
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Links are also hypothesized to make the outcomes/implications on 
future financial performance of non-financial measures more transparent.  If 
causal links discussion affects information weighting and use, as hypothesized, 
then providing a links discussion about how non-financial measures are linked 
to future financial performance will lead to an increased belief that non-
financial measures are relevant for valuation.  Accordingly, I propose the 
following hypothesis: 
H4: The frequency of references to performance on non-financial 
measures in investors’ written explanations for their judgments will be 
higher for investors who receive the causal links discussion than for 
investors who do not receive it.  
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Chapter 4: Description of Method 
To test the hypotheses, I conducted an experiment in which 87 MBA 
students at a large state university participated.  Participants were recruited by 
way of an e-mail notice and were paid a flat wage of $10 plus the chance of 
winning a random cash drawing.  On average, study participants had 5.7 years of 
work experience and had completed 2.5 accounting classes and 3.1 finance 
classes.  Eighty-three percent indicated that they had invested in common stock or 
in a common stock mutual fund; 100 percent indicated that they had invested or 
planned to invest in common stock.  
Participants were asked to assume the role of an investor evaluating the 
common stock of a pharmaceutical firm.  The hypothetical firm was profitable, 
with products already in the market and products in the pipeline.  This context is 
the prototypical inter-temporal intangibles situation, with R&D expenditures 
incurred up front, and cash and earnings payoffs in subsequent years.  The 
hypothetical firm was developed based on a composite of profitable publicly-
traded pharmaceutical firms with less than $500 million in annual revenues. 
Two factors were manipulated and fully crossed.  When combined with a 
control condition, this results in a 2 X 2 plus 1 between-subjects design.  The first 
manipulated factor was causal links discussion, where participants who received a 
report on non-financial measures, either received it with or without a 
supplemental discussion of how the firm’s non-financial intangibles measures 
were linked to future financial performance.  The second manipulated factor was 
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level of non-financial performance, where the disclosing firm was identified as 
having either above-average performance (HI NFM) or below-average 
performance (LO NFM) on non-financial measures.  This performance 
manipulation was used to examine whether and when investors incorporate the 
content of non-financial intangibles disclosures in their judgments.  The “plus 1” 
was a control condition where participants received neither the report on non-
financial measures nor the links discussion.  The specific non-financial measures 
that were manipulated to be above-average and below-average were based on key 
factors identified in pharmaceutical companies’ Form 10K filings and annual 
reports.  The specific levels chosen to be HI, LO, and Industry Average were 
based on disclosures in pharmaceutical companies’ Form 10K filings and annual 
reports.  All materials were pre-tested with Ph.D. students, including some with 
professional financial analysis experience, and some with experience in the 
pharmaceutical industry. Results from pre-testing indicated that the non-financial 
measures that were manipulated and the selected levels of performance were 
considered reasonable and realistic by the participants. 
In Part A of the experiment, participants were provided with background 
information about the pharmaceutical company.  At this time, participants in the 
causal links discussion condition also received a supplemental discussion of how 
the firm’s non-financial intangibles measures were linked to future financial 
performance.  The supplemental discussion contained a narrative, graphical, and 
matrix description of the links (see Appendix A).  
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In Part B, participants were provided with a stylized press release 
reporting current year results.  The press release discussed financial results for the 
year just ended, and included comparative income statements, condensed balance 
sheets, and a report on the company’s non-financial measures.   
The level of non-financial performance was manipulated in this stage of 
the experiment.  The non-financials report for participants in the HI NFM (LO 
NFM) condition showed the company to be performing above (below) the 
industry average on its key linked non-financial measures (see Appendix A).  The 
HI/LO NFM manipulation was intended to reflect the variation in firms’ values 
that investors would need to differentiate (even when R&D spending is held 
constant between firms).  Participants in the control condition did not receive a 
report on the company’s non-financial measures.  Otherwise, the discussion of 
financial results, income statements, and condensed balance sheets were identical 
in all conditions. 
After reviewing the background information and the earnings 
announcement package, participants were instructed to make predictions of the 
company’s future financial performance (next year’s net income, next year’s 
revenue, net income growth, and revenue growth).  The next year net income and 
revenue questions were open-ended questions with no response scale provided.  
Participants also answered an open-ended question on how they arrived at their 
net income judgment.  Participants were also asked for second order judgments, 
including the level of confidence in the accuracy of their next year net income and 
revenue judgments, and an optimistic and pessimistic prediction for next year net 
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income and next year revenue, representing the upper and lower bounds, 
respectively, of a 95% confidence interval. 
The session concluded with participants responding to a series of post-
experimental questions about the case, including manipulation checks and 
demographic questions, including a question asking participants to rate their 
familiarity level with the pharmaceutical industry. 
I use next year’s revenue and revenue growth (3 to 5 years out) as the 
primary dependent variables for this study.  As discussed earlier, because of the 
discretionary nature surrounding R&D spending and the assumptions that 
investors must make about the future R&D spending strategy of the firm, 
earnings-related dependent variables are noisier.  At the same time, revenue is an 
input into valuation (as it is an input into earnings), so there is validity to using it 
as a dependent variable, without it being confounded by expectations of R&D 
expense.  Also, although I use next year’s revenue and revenue growth (3 to 5 
years out) interchangeably as operationalizations of future financial performance, 
different investor perceptions of the timing of the benefits from R&D (brought on 
by disclosure of non-financial measures and/or familiarity and cause-and-effect 
links) could lead to different results for these two dependent variables. 
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Chapter 5: Results  
5.1  MANIPULATION AND OTHER CHECKS 
The results from the manipulation check questions reveal that participants 
saw the two manipulated variables as intended.  For the causal links discussion 
variable, I reasoned that the usefulness of non-financial measures would be higher 
for participants who received the links discussion than for those who did not.  As 
expected, participants who received the causal links discussion rated the 
usefulness of non-financial measures (in predicting net income) higher (mean of 
11.00 on a 15-point scale with 1 as “not at all useful” and 15 as “extremely 
useful”) than those who did not receive the links discussion (mean of 9.77) 
(F=2.369, p=.06, one-tailed).   
For the non-financial measures performance manipulation, I reasoned that 
the performance on non-financial measures should affect participants’ evaluations 
of management’s competence and the quality of the job that management was 
doing in its stewardship of the company.  As expected, participants receiving HI 
NFM performance rated management’s competence higher (mean of 9.83 on a 15-
point scale with 1 as “not at all competent” and 15 as “very competent”) than 
participants receiving LO NFM performance (mean of 8.63) (F=5.900, p=.01, 
one-tailed).  Similarly, participants receiving HI NFM performance rated 
management’s stewardship of the company higher (mean of 9.49 on a 15-point 
scale with 1 as “very poor job” and 15 as “outstanding/excellent job”) than 
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participants receiving LO NFM performance (mean of 8.24) (F=6.290, p=.01, 
one-tailed).  Overall, these results indicate that the manipulations were successful.  
The data analysis in the following sections is organized as follows:  In 
Section 5.2, I provide evidence of noise in the net income and net income growth 
measures, which leads to these measures being dropped from subsequent analysis.  
In Section 5.3, I analyze the data for the full sample on the primary hypotheses 
(Hypotheses 1 and 2).  The results are mixed, so I do not perform the analysis of 
the mediating processes.  In Section 5.4, I analyze the data for the high familiarity 
subset.  In Sections 5.5 and 5.6, I analyze the data for the low familiarity subset, 
the investors who were most likely to be affected by the provision of 
supplemental links.  In Section 5.5, I analyze the data for the primary hypotheses 
and in Section 5.6, I analyze the data for the intermediate stage judgments.  In 
Section 5.7, I analyze the causal models elicited from participants during the 
experiment, which may provide information on the causal models used by 
investors.  Finally, in Section 5.8, I analyze the data for second-order judgments.  
A summary of the results organized by hypotheses is as follows: 
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Table 1 - Summary of Results  
     Full Sample  Low Familiarity 
Hypothesis 1 (No effect of expanded NFM disclosure alone)   
     Partially supported Supported 
Hypothesis 2 (Effect of causal links discussion)     
     Partially supported Supported  
Hypothesis 3 (Recall of non-financial performance) 
    N/A   Not supported 
Hypothesis 4 (References to NFM in explanations) 
    N/A   Partially supported 
5.2  NOISE IN THE NET INCOME AND NET INCOME GROWTH MEASURES 
Earlier, I provided a rationale for my choice of revenue and revenue 
growth as the primary dependent variables for this study.  Because of the 
discretionary nature surrounding R&D spending, investors would have to make 
assumptions about the future R&D spending levels of the firm, leading to 
increased noise in the net income and net income growth measures. 
As discussed earlier, participants were asked to explain how they arrived 
at their net income judgments.  Analysis of participants’ explanations for their net 
income judgments indicates that these judgments were strongly influenced by 
participants’ expectations and assumptions about R&D expense.  Seventy-seven 
percent of participants referred to R&D expense in their explanations of how they 
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arrived at their net income judgment, and 56% of participants indicated that they 
adjusted R&D expense from the current year to arrive at their next year net 
income estimate.  Some participants believed that R&D in 2002 was unusually 
high, so R&D expense would be lower in the next year.  Some participants 
believed that R&D expense would be higher next year, either to sustain the many 
products in the company’s research and development pipeline (those in the HI 
NFM condition) or to catch up to their competitors who had more products in 
their pipeline (those in the LO NFM condition).  These idiosyncratic adjustments 
for R&D made by participants contributed to the noise in the net income and net 
income growth dependent measures.  Accordingly, these net income measures are 
dropped from the analysis, and I focus on next year revenue and revenue growth 
in the analysis and discussion that follows. 
5.3  PRIMARY HYPOTHESES - FULL SAMPLE  
Descriptive statistics for the main dependent variables are reported in 
Table 2 and are presented in a graph in Figure 3. 
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Table 2 - Descriptive Statistics (Full Sample) 
Mean Next Year Revenue Judgments (Standard Deviation)  
No Links  Links 
   HI NFM   184.66   189.64 
(14.82)  (11.71) 
       N=18   N=18 
Control 184.01 
  (7.21) 
  N=17 
   LO NFM   187.57   183.43 
(13.26)  (14.27) 
N=17   N=17 
 
Mean Revenue Growth Judgments (Standard Deviation) 
       No Links  Links 
   HI NFM   11.47   11.68 
(1.83)   (1.78)  
N=18   N=18 
Control 10.54 
  (2.15) 
  N=17 
   LO NFM   9.12   9.40 
       (3.16)   (3.45) 
       N=17   N=17 
 
This table shows the descriptive statistics for next year revenue and revenue growth 
judgments for the full sample.  Study participants were randomly assigned to one of five 
conditions, in a 2 X 2 plus 1 between-subjects design.  In these conditions, they were 
provided with no disclosures of non-financial measures (control condition), disclosures of 
non-financial measures with no supplemental links information (no links), or disclosures 
of non-financial measures with supplemental links information (links).  For the no links 
and links conditions, the disclosures of non-financial measures revealed the company to 
be performing above-average (HI NFM) or below-average (LO NFM) on key non-
financial measures.  As part of the experimental task, participants were asked to provide 
judgments of next year revenue and revenue growth (3 to 5 years out).  The next year 
estimate was elicited as an open-ended question (no response scale was used).  
Participants provided the growth judgment on a 15-point Likert Scale, with the end points 
labeled 1=“very weak” and 15 = “very strong”).  
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FIGURE 3 - Full Sample Results 
Panel A (Full Sample-Next Year Revenue) 
 
DV = Next Year Revenue 
 
 
Panel B (Full Sample-Revenue Growth) 
 

































Effect of Disclosing Non-Financial Measures Alone (Hypothesis 1) 
Recall that hypothesis 1 predicts that investors will not differentiate 
between HI NFM, LO NFM, and no NFM firms if non-financial measures are 
disclosed alone.  To test this, a series of 1 X 3 ANOVA’s was performed, with 
condition (no NFM vs. HI NFM-No links vs. LO NFM-No links) as the between-
subjects variable.8  Results are reported in Table 3. 
Table 3 - Tests of Hypothesis One (Full Sample) 
Panel A: Analysis of Variance with next year revenue as the dependent 
variable 
 
Source     d.f.  F-statistic Probability 
 
Between group   2  .408  .667 
Within group    49 
 
Panel B: Analysis of Variance with revenue growth as the dependent variable 
 
Source     d.f.  F-statistic Probability 
 
Between group   2  4.131  .022 
Within group    49 
Contrasts      t-statistic 
 HI NFM vs. LO NFM    2.677  .01 
 HI NFM vs. No NFM    1.368  .18 
 LO NFM vs. No NFM   1.541  .13 
 
When next year revenue is used as the dependent variable, the results of 
the ANOVA indicate no significant effect for condition (F=.408, p=.67) (Table 3, 
                                                 
8 A MANOVA with 2 dependent variables (revenue and revenue growth) was performed before 
running the ANOVA analyses (Wilks’ Lambda, F=2.375, p=.06). 
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Panel A).  This “no effect” result suggests that investors do not distinguish 
between HI NFM, LO NFM, and no NFM firms, consistent with hypothesis 1.   
When revenue growth (3 to 5 years out) is used as the dependent variable, 
the results of the omnibus 1 X 3 ANOVA indicate a significant effect for 
condition (F=4.131, p =.02)9 (Table 3, Panel B).  Follow-up contrasts indicate that 
revenue growth estimates were higher for investors in the HI NFM condition than 
for investors in the LO NFM condition (t=2.677, p=.01, two-tailed), using the 
separate variance approach outlined by Maxwell and Delaney (1990), to account 
for heterogeneity of variances in the data.  For the revenue growth dependent 
variable, investors, even without links, were able to differentiate between the 
above-average and below-average firm.  This result is not consistent with 
hypothesis 1.  Other follow-up contrasts indicate that revenue growth estimates 
for investors in the HI NFM condition were not significantly different than 
revenue growth estimates for investors in the no NFM condition (t=1.368, p=.18, 
two-tailed).  Additionally, revenue growth estimates for investors in the LO NFM 
condition were not significantly different than revenue growth estimates for 
investors in the no NFM condition (t=1.541, p=.13, two-tailed). 
                                                 
9 The standard deviations for revenue growth judgments in the 5 conditions are significantly 
different (Levene statistic = 5.458, thus the null hypothesis of homogenous variances can be 
rejected at p<.01).  The implications of this violation of the assumption of homogeneous variances 
are varied.  Hays (1994) and Maxwell and Delaney (1990) conclude that an omnibus ANOVA test 
is robust to violations of the assumption of homogeneous variances “provided that the number of 
cases in each sample is the same” (Hays, 1994, pg. 407).  Hays (1994, pg. 407) goes on to define 
“same” as the ratio of the number of cases in the largest group to the number of cases in the 
smallest group being less than 1.5, which is the case for this study.  Accordingly, the ANOVA 
reported below is neither liberal nor conservative, despite the violation of homogeneous variances.  
On the other hand, Maxwell and Delaney (1990) report that “tests of contrasts are not robust to 
heterogeneity”, even with equal sample sizes, requiring the use of a “separate variance approach” 
(Maxwell and Delaney, 1990), or the use of nonparametric tests that are distribution free.   
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In summary, providing non-financial measures alone was effective in 
helping investors differentiate between HI NFM and LO NFM firms when 
investors were asked about revenue growth, but not when asked about next period 
revenue.  This suggests that, on average, investors brought enough industry 
knowledge (familiarity) to the table (i.e. they had their own links) to use NFM, 
even with disclosure alone (without links).  The fact that NFM performance was 
more readily reflected in the revenue growth dependent variable (3 to 5 years out) 
than in the next year revenue estimate suggests that the familiarity that some 
investors already had linked NFM performance to periods beyond, but not 
including, the immediate next year.  This could be the case if investors observe 
the level of NFM performance and evaluate the historical performance as HI or 
LO (as they did in the performance manipulation check questions), but have 
difficulty understanding the timing of benefits and translating historical NFM 
performance to future financial performance in particular periods.  Absent the 
links, it appears in this case that there is a belief among investors that the financial 
effects of current period NFM performance would be realized more in the long-
term. 
Effect of Disclosing Non-Financial Measures with Causal Links Discussion 
(Hypothesis 2) 
Recall that hypothesis 2 predicts that investors can better differentiate 
between HI NFM and LO NFM firms when links are provided.  To test this, a 
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series of 2 x 2 ANOVA’s was performed, with causal links discussion and NFM 
performance as the independent variables.10  Results are reported in Table 4. 
Table 4 - Tests of Hypothesis Two (Full Sample) 
Panel A: Analysis of Variance with next year revenue as the dependent 
variable 
 
Source     d.f.  F-statistic Probability 
 
NFM performance   1  .259  .612 
Links     1  .016  .898 
NFM performance X Links  1  1.977  .082 (1-tailed) 
 
Panel B: Analysis of Variance with revenue growth as the dependent variable 
 
Source     d.f.  F-statistic Probability 
 
NFM performance   1  13.430  <.01 
Links     1  .149  .701 
NFM performance X Links  1  .004  .476 (1-tailed) 
     
First, I examine the effect of providing causal links with next year revenue 
as the dependent variable.  As indicated in table 4, panel A, there is a marginally 
significant links by performance interaction (F=1.977, p=.08, one-tailed11), with 
no main effect for either links or performance.  Follow-up simple effects tests 
indicate that, when NFM are provided without causal links, revenue judgments 
for HI NFM and LO NFM are not significantly different (F=.402, p=.53).  When 
                                                 
10 A MANOVA with 2 dependent variables (revenue and revenue growth) was performed before 
running the ANOVA analyses (for the interaction, Wilks’ Lambda, F=.970, p=.38) (however, as 
the analysis for hypothesis 1 above indicates, in this instance, next year revenue and revenue 
growth may be capturing perceptions of the differential timing of future revenues). 
11 McNeil, Newman, and Kelly (1996) advise extending the usual logic of a one-sided hypothesis 
test to directional tests of single-degree-of-freedom interactions between two factors. 
 44 
causal links are added, revenue predictions are (marginally) higher for HI NFM 
vs. LO NFM (F=1.834, p=.09, one-tailed), consistent with hypothesis 2. 
When revenue growth is used as the dependent variable (table 4, panel B), 
there is no significant interaction (F=.004, p=.48, one-tailed), which is not 
consistent with hypothesis 2.  There is a main effect for NFM performance 
(F=13.430, p<.01), and no effect for links (F=.149, p=.70).  This is consistent 
with the earlier result for hypothesis 1 that investors’ judgments of revenue 
growth reflect performance on NFM even when causal links are not provided.   
The mixed results for the full sample suggest that the causal links 
discussion informs investors about the immediacy (but not the direction or 
magnitude, which they already know about) of future financial effects from 
current period non-financial performance.   Even without causal links, full sample 
participants link current non-financial performance to revenue growth 3 to 5 years 
out.  But these participants do not reflect non-financial performance in the more 
immediate “next year revenue” dependent measure, unless they receive the causal 
links discussion. 
The premise underlying hypotheses 1 and 2 is that causal links provide 
information about cause-and-effect relations, allowing investors to understand 
non-financial measures and their implications for future financial performance.  
However, if investors already have familiarity with the industry setting to use 
non-financial measures, then providing the links may not make a difference.  This 
may explain the mixed results observed above with the full sample.   
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To better understand the role of industry familiarity in using non-financial 
measures, I partition my sample and separately analyze the responses for 
participants having high familiarity and participants having low familiarity.  High 
familiarity participants are expected to have pre-existing causal models, so their 
“no links” judgments should resemble the “with links” judgments of low 
familiarity participants.  At the same time, providing causal links may be 
redundant for these participants.  Low familiarity participants are expected to 
benefit the most from having causal links provided, so focusing on low familiarity 
participants provides for a stronger test of the role of causal links in moderating 
judgments about non-financial measures.   
In the demographic questions in the experimental materials, I asked 
participants to indicate their level of familiarity with the pharmaceutical industry 
on a 7-point scale, with the endpoints labeled 1=“not familiar at all” and 7=“very 
familiar.”  To partition the sample, I designated those participants who rated 
themselves 4 or lower as “low familiarity” participants (n=63), and those 
participant who rated themselves 5 or higher as “high familiarity” participants 
(n=24). 12   
                                                 
12 To explicitly test the joint effect of NFM, links, and familiarity, I ran a 2 X 2 X 2 MANOVA 
(using the 2 dependent variables identified earlier), with NFM performance, links, and a 
dichotomous familiarity variable, coding participants who rated themselves a 5 or higher on 
familiarity with the pharmaceutical industry as High and participants who rated themselves a 4 or 
lower on familiarity as Low (note that this results in unequal cell sizes).  The results of the 3-way 
MANOVA are significant (F=4.706, p=.013).  However, this result for this MANOVA is sensitive 
to the “cut-point” used to determine High and Low familiarity participants.  When I code 
participants who rated themselves a 4 or higher on familiarity as High and participants who rated 
themselves a 3 or lower on familiarity as Low, the results of the MANOVA are not significant 
(F=1.651, p=.20).  When I code participants who rated themselves a 3 or higher on familiarity as 
High and participants who rated themselves a 2 or lower on familiarity as Low, the results of the 
MANOVA are significant (F=2.768, p=.07).  Consequently, these ex post analyses should be 
interpreted with caution. 
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5.4  HIGH FAMILIARITY SUBSET 
Descriptive statistics for the main dependent variables for the twenty-four 
high familiarity participants are reported in Table 5.  
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Table 5 - Descriptive Statistics (High Familiarity Subset) 
Mean Next Year Revenue Judgments (Standard Deviation)  
No Links  Links 
   HI NFM   185.77   193.20 
(16.11)  (16.08) 
N=5   N=5 
Control 183.75 
  (6.29) 
  N=4 
   LO NFM   185.50   190.83 
(11.73)  (10.21) 
N=4   N=6 
   
Mean Revenue Growth Judgments (Standard Deviation) 
       No Links  Links 
HI NFM   13.02   12.00 
(1.86)   (0.71) 
 N=5   N=5 
Control 11.40 
  (2.70) 
  N=4 
   LO NFM   6.65   11.35 
       (3.30)   (3.80) 
       N=4   N=6 
 
This table shows the descriptive statistics for next year revenue and revenue growth 
judgments for participants who rated themselves 5 to 7 on “familiarity with the 
pharmaceutical industry.”  Study participants were randomly assigned to one of five 
conditions, in a 2 X 2 plus 1 between-subjects design.  In these conditions, they were 
provided with no disclosures of non-financial measures (control condition), disclosures of 
non-financial measures with no supplemental links information (no links), or disclosures 
of non-financial measures with supplemental links information (links).  For the no links 
and links conditions, the disclosures of non-financial measures revealed the company to 
be performing above-average (HI NFM) or below-average (LO NFM) on key non-
financial measures.  As part of the experimental task, participants were asked to provide 
judgments of next year revenue and revenue growth (3 to 5 years out).  The next year 
estimate was elicited as an open-ended question (no response scale was used).  
Participants provided the growth judgment on a 15-point Likert Scale, with the end points 
labeled 1=“very weak” and 15 = “very strong”).     
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Recall that hypothesis 1 (directed toward low familiarity investors) 
predicted that investors will not differentiate between HI NFM, LO NFM, and no 
NFM firms if non-financial measures are disclosed alone.  However, for high 
familiarity investors who have well-developed causal models involving non-
financial measures, I expect them to differentiate between the HI NFM, LO NFM, 
and no NFM firms.  To test this, I performed a series of ANOVA’s on the high 
familiarity subset, with condition (no NFM vs. HI NFM-No links vs. LO NFM-
No links) as the between-subjects variable.  Results are reported in Table 6. 
 
Table 6 - Tests of Hypothesis One (High Familiarity Subset) 
Panel A: Analysis of Variance with next year revenue as the dependent 
variable 
 
Source     d.f.  F-statistic Probability 
 
Between group   2  .032  .97 
Within group    10 
 
Panel B: Analysis of Variance with revenue growth as the dependent variable 
 
Source     d.f.  F-statistic Probability 
 
Between group   2  6.889  .01 
Within group    10 
 
When next year revenue is used as the dependent variable, the results of 
the ANOVA indicate no significant effect for condition (F=.032, p=.97) (table 6, 
panel A).  This “no effect” result is consistent with hypothesis 1, but is not 
consistent with the notion that high familiarity investors bring knowledge about 
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non-financial measures to the task.  When revenue growth (3 to 5 years out) is 
used as the dependent variable, the results of the omnibus 1 X 3 ANOVA for the 
high familiarity participants indicate a significant effect for condition (F=6.889, 
p=.01) (table 6, panel B), consistent with the notion that high familiarity investors 
are able to differentiate between above and below-average firms and to reflect 
these differences in judgments of future financial performance, even when causal 
links are not provided.  Given the especially small sample size and the sensitivity 
to the cut point used to partition high and low familiarity investors, these results 
should be interpreted with caution. 
Effect of Disclosing Non-Financial Measures with Causal Links Discussion 
(Hypothesis 2) 
For high familiarity investors, providing links is expected to be redundant, 
leading to a prediction of a main effect for performance and no performance by 
links interaction.  To test this prediction, I performed a series of 2 x 2 ANOVA’s 
on the high familiarity subset, with causal links discussion and NFM performance 









Table 7 - Tests of Hypothesis Two (High Familiarity Subset) 
 
Panel A: Analysis of Variance with next year revenue as the dependent 
variable 
 
Source     d.f.  F-statistic Probability 
 
NFM performance   1  .045  .834 
Links     1  1.061  .318 
NFM performance X Links  1  .029  .868 
 
Panel B: Analysis of Variance with revenue growth as the dependent variable 
 
Source     d.f.  F-statistic Probability 
 
NFM performance   1  8.006  .012 
Links     1  2.200  .157 
NFM performance X Links  1  5.316  .035 
 
First, I examine the effect of providing causal links with next year revenue 
as my dependent variable.  As indicated in table 7, panel A, there is no significant 
links by NFM performance interaction, and no main effect for either links or 
NFM performance, contrary to expectations. 
When revenue growth is used as the dependent variable (table 7, panel B), 
there is a significant links by NFM performance interaction (F=5.316, p=.04, one-
tailed).  Follow-up simple effects tests indicate that, when NFM are provided 
without causal links, revenue growth judgments for HI NFM and LO NFM are 
significantly different.  When causal links are added, revenue growth predictions 
become less differentiated, contrary to expectations.  Once again, given the 
especially small sample size and the sensitivity to the cut point used to partition 
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high and low familiarity investors, these results should be interpreted with 
caution. 
5.5  LOW FAMILIARITY SUBSET - PRIMARY HYPOTHESES 
Descriptive statistics for the main dependent variables for the 63 low 
familiarity participants are reported in Table 8 and are presented in a graph in 
Figure 4.  
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Table 8 - Descriptive Statistics (Low Familiarity Subset) 
Mean Next Year Revenue Judgments (Standard Deviation)  
No Links  Links 
   HI NFM   184.23   188.27 
(14.98)  (10.04) 
N=13   N=13 
Control 184.08 
  (7.70) 
  N=13 
   LO NFM   188.21   179.38 
(14.07)  (14.92) 
N=13   N=11 
   
Mean Revenue Growth Judgments (Standard Deviation) 
       No Links  Links 
HI NFM   10.87   11.55 
(1.48)   (2.07)  
N=13   N=13 
Control 10.28 
  (2.00) 
  N=17 
   LO NFM   9.88   8.34 
       (2.82)   (2.87) 
       N=13   N=11 
 
This table shows the descriptive statistics for next year revenue and revenue growth 
judgments for participants who rated themselves 1 to 4 on “familiarity with the 
pharmaceutical industry.”  Study participants were randomly assigned to one of five 
conditions, in a 2 X 2 plus 1 between-subjects design.  In these conditions, they were 
provided with no disclosures of non-financial measures (control condition), disclosures of 
non-financial measures with no supplemental links information (no links), or disclosures 
of non-financial measures with supplemental links information (links).  For the no links 
and links conditions, the disclosures of non-financial measures revealed the company to 
be performing above-average (HI NFM) or below-average (LO NFM) on key non-
financial measures.  As part of the experimental task, participants were asked to provide 
judgments of next year revenue and revenue growth (3 to 5 years out).  The next year 
estimate was elicited as an open-ended question (no response scale was used).  
Participants provided the growth judgment on a 15-point Likert Scale, with the end points 
labeled 1=“very weak” and 15 = “very strong”).     
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FIGURE 4 - Low Familiarity Subset Results 
Panel A (Low Familiarity Subset-Next Year Revenue) 
 
DV= Next Year Revenue 
 
Panel B (Low Familiarity Subset-Revenue Growth) 
 




























Effect of Disclosing Non-Financial Measures Alone (Hypothesis 1) 
To re-test the hypothesis that investors will not differentiate between HI 
NFM, LO NFM, and no NFM firms if non-financial measures are disclosed alone, 
I performed a series of ANOVA’s on the low familiarity subset, with condition 
(no NFM vs. HI NFM-No links vs. LO NFM-No links) as the between-subjects 
variable.13  Results are reported in Table 9. 
 
Table 9 - Tests of Hypothesis One (Low Familiarity Subset) 
Panel A: Analysis of Variance with next year revenue as the dependent 
variable 
 
Source     d.f.  F-statistic Probability 
 
Between group   2  .442  .65 
Within group    36 
 
Panel B: Analysis of Variance with revenue growth as the dependent variable 
 
Source     d.f.  F-statistic Probability 
 
Between group   2  .696  .51 
Within group    36 
 
When next year revenue is used as the dependent variable, the results of 
the ANOVA indicate no significant effect for condition (F=.442, p=.65) (table 9, 
panel A).  This “no effect” result is consistent with hypothesis 1.  When revenue 
growth (3 to 5 years out) is used as the dependent variable, the results of the 
                                                 
13 A MANOVA with 2 dependent variables (revenue and revenue growth) was performed before 
running the ANOVA analyses (all measures, highest F=1.04, lowest p=.36). 
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omnibus 1 X 3 ANOVA for the low familiarity participants now indicate no 
significant effect for condition (F=.696, p=.51) (table 9, panel B), consistent with 
hypothesis 1.   
Overall, as predicted, for the low familiarity subset, disclosure alone of 
non-financial measures does not lead to more differentiated investor judgments, 
even when NFM performance is unambiguously above or below-average.  
Effect of Disclosing Non-Financial Measures with Causal Links Discussion 
(Hypothesis 2) 
To re-test the prediction that investors can better differentiate between HI 
NFM and LO NFM firms when causal links are provided, I performed a series of 
2 x 2 ANOVA’s on the low familiarity subset, with causal links discussion and 
NFM performance as the independent variables.14  Results are reported in Table 
10. 
 
                                                 
14 A MANOVA with 2 dependent variables (revenue and revenue growth) was performed before 
running the ANOVA analyses (for the interaction, Wilks’ Lambda, F=2.773, p=.04, one-tailed). 
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Table 10 - Tests of Hypothesis Two (Low Familiarity Subset) 
 
Panel A: Analysis of Variance with next year revenue as the dependent 
variable 
 
Source     d.f.  F-statistic Probability 
 
NFM performance   1  .405  .528 
Links     1  .385  .538 
NFM performance X Links  1  2.779  .051 (1-tailed) 
 
Panel B: Analysis of Variance with revenue growth as the dependent variable 
 
Source     d.f.  F-statistic Probability 
 
NFM performance   1  9.936  <.01 
Links     1  .417  .522 
NFM performance X Links  1  2.747  .052 (1-tailed) 
First, I examine the effect of providing links with next year revenue as my 
dependent variable.  As indicated in table 10, panel A, there is a significant links 
by performance interaction (F=2.779, p=.05, one-tailed), with no main effect for 
either links or performance.  Follow-up simple effects tests indicate that, when 
NFM are provided without causal links, revenue judgments for HI NFM and LO 
NFM are not significantly different (F=.555, p=.46) (means are in the wrong 
direction as well).  When causal links are added, revenue predictions are higher 
for HI NFM vs. LO NFM (F=2.542, p=.06, one-tailed), consistent with hypothesis 
2. 
When revenue growth is used as the dependent variable (table 10, panel 
B), there is a significant links by performance interaction (F=2.747, p=.05, one-
tailed).  Follow-up simple effects tests indicate that, when NFM are provided 
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without causal links, revenue growth judgments for HI NFM and LO NFM are not 
significantly different (F=1.168, p=.29).  When causal links are added, revenue 
growth predictions are higher for HI NFM vs. LO NFM (F=11.084, p<.01, one-
tailed), consistent with hypothesis 2.   
Overall these results using the low familiarity subset are more consistent 
with the hypothesis that providing causal links leads to more differentiated 
judgments of future financial performance.  The stronger results with the low 
familiarity subset are consistent with the theory that causal links provide investors 
with the causal models to understand and use non-financial measures.  The 
weaker effects of links with the full sample earlier could be due to some investors 
in the full sample already having the familiarity (and the causal models) to 
understand and use non-financial measures in the pharmaceutical industry.  For 
these investors, links did not help to differentiate above and below-average firms 
because investors could do it on their own.  Once the high familiarity investors 
were eliminated from the analysis, the effects of links are much stronger.  
Essentially, having a causal model is necessary for investors to process non-
financial information, and investors can either possess the model based on 
industry familiarity from prior work experience and schooling (antecedents of 
“knowledge” in the Libby and Lift, 1993, model) or can acquire it from 
supplemental links discussion (“environment” in the Libby and Luft, 1993, 
model).   
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5.5  LOW FAMILIARITY SUBSET - MEDIATING PROCESSES HYPOTHESES 
Given the overall effect for providing causal links observed above, it is 
possible to conclude that, without causal links or pre-existing familiarity with the 
industry, investors do stray from the path outlined in Figure 1 and do not 
incorporate non-financial intangibles information in their performance judgments.  
What is yet unknown is when (i.e. at which node in Figure 1) this breakdown 
occurs.  In this section, I provide evidence on the specific investors’ processes 
that are affected by the provision of causal links (i.e. looking at how providing 
cause-and-effect links helps low familiarity investors use non-financial 
intangibles information). 
In Chapter 3, I suggested that providing cause-and-effect links increases 
investors’ incorporation of non-financial information, by affecting the information 
retention and/or information use/weighting processes.  For these processes, I 
identified testable hypotheses involving intermediate stage cognitions and 
judgments, to determine if the processes are affected by causal links discussion. 
If providing causal links gives investors a structure to receive new non-
financial intangibles information, low familiarity investors with causal links 
would be more likely to retain information about linked non-financial intangibles, 
relative to low familiarity investors without links.  Differences in information 
retention should be reflected in participants’ recall of non-financial information. 
As part of the post-experimental questionnaire, participants who received 
a report on non-financial measures completed a recall task, asking for details 
about the non-financial measures report that they saw.  They were asked (1) for 
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the number of projects in the hypothetical company’s development pipeline, (2) 
whether the number of projects currently in the pipeline was higher than, the same 
as, or lower than the industry average, and (3) the number of years that it takes the 
hypothetical company to complete the cycle from initial investment to 
development.  Results from the recall task are presented in Table 11. 
Table 11 - Recall Data (Low Familiarity Subset) 
Percentage of Participants Answering Recall Question Correctly 
 
Question      Links  No Links 
 
Number of Projects in the Development Pipeline 46%  62% 
 
Number of Projects in the Development Pipeline 
 Relative to Industry Average   63%  77% 
 
Time to Completion of New Projects   88%  77% 
 
Recall that hypothesis 3 predicts that recall of performance on non-
financial measures will be higher for those investors receiving the causal links 
discussion than for those investors who do not receive it.  The results in Table 11 
indicate that the proportion of low familiarity participants correctly recalling the 
details of performance on key non-financial measures is not significantly higher 
(chi-square statistic<2, for all three questions) for participants in the causal links 
condition vs. participants in the no links condition.  This result is not consistent 
with hypothesis 3, the prediction that providing causal links leads to greater 
retention of non-financial information.  The results of the recall tests suggest that 
even for investors with low familiarity and no links, they stayed on the right path 
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(“YES”) at Node A in Figure 1.15  The results of these recall tests also suggest 
that the differences in judgments of future financial performance observed earlier 
are attributable to causal links affecting use or weighting of NFM, and not to links 
affecting acquisition/retention. 
To more directly examine the notion that the causal links discussion 
affects how NFM are used,16 I examine the explanation data to see if participants 
referred to using NFM information when arriving at their (net income) 
performance judgments.  Recall that participants were asked to explain how they 
arrived at their net income prediction.  If causal links affect participants’ use of 
non-financial measures, non-financial measures should be mentioned more 
frequently in participants’ explanations, which was formally stated as Hypothesis 
4. 
I reviewed low familiarity participants’ written explanations for their net 
income judgments.  Compared to participants in the no links condition, those in 
the links condition refer more often to non-financial measures (67% to 60%), 
                                                 
15 Although the differences in recall proportions are not statistically significant, the higher recall 
level (on two questions) for investors who did not receive causal links discussion is curious.   One 
possible explanation is that the causal links discussion led to investors having an affective reaction 
to the level of NFM performance, where they retain the gist of the non-financial information in 
memory, but not the specific details.  To examine this possibility, I re-analyzed the data for the 
first recall question, this time using a standard of “directional correctness,” where responses for 
participants in the HI (LO) NFM condition that were higher (lower) than the industry average 
were classified as correct.  Using this new standard of directional correctness, 73% of participants 
in the “no links” condition and 75% of participants in the “with links” condition correctly 
answered the recall question.  This is preliminary evidence that causal links discussion may have 
induced a stronger affective reaction, which could have had a negative effect on recall of specific 
NFM details. 
16 Similar to the results for the full sample, low familiarity participants who received the causal 
links discussion rated the usefulness of non-financial measures (in predicting net income) higher 
(mean of 10.87) than those who did not receive the links discussion (mean of 9.27) (F=3.269, 
p=.04, one-tailed).  
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refer more often to one of the three linked non-financial measures (67% to 57%), 
and compare NFM performance to industry average more often (50% to 19%).  
Although the directional pattern of these proportions is consistent with 
predictions, only the difference in comparison of NFM performance to industry 
average is statistically significant (chi-square statistic is 5.27, p<.025).  Overall, 
these results suggest that low familiarity investors receiving the causal links 
discussion are more likely to use (and refer to) non-financial measures.  
Interestingly, significantly more participants refer to the company’s NFM 
performance relative to industry average in their judgment explanations when 
they receive causal links than when they do not, but the recall data presented 
earlier show that recall of NFM performance relative to industry average is not 
different across conditions.  In other words, the overall differences observed 
earlier for hypotheses 1 and 2 appear to be driven by differences in whether and 
how non-financial information is used, and not by differences in the retention of 
that information. 
5.6  ANALYSIS OF CAUSAL MODELS USED BY INVESTORS 
In this section, I analyze the data collected from participants about the 
causal models that they used while participating in the study.  In the last part of 
the study, participants were provided with a sheet of paper with eight boxes, 
representing the eight stages of the company’s innovation process (consistent with 
the innovation process outlined in the links manipulation).  The boxes were 
scrambled on the page, and participants were asked to draw arrows between the 
boxes to indicate how the company’s actions, non-financial measures, and future 
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financial outcomes were connected.  I perform two analyses in this section.  First, 
I examine whether the causal models drawn by participants were affected by 
whether they received the causal links discussion and whether they had high or 
low familiarity with the industry setting. Of particular interest are the causal 
models drawn by participants who did not receive the causal links discussion, 
because this is an opportunity to see what causal models are held by investors 
without the influence of a provided causal links discussion.  In the second 
analysis, I examine the connection between the causal models drawn by investors 
and their judgments of future financial performance.  
 The causal models drawn by participants fell into 3 primary categories.  
Sixty-five participants (75%) drew primarily linear models, where boxes were 
connected in sequential fashion.  Most importantly, non-financial measures were 
part of the sequential chain, where applications would lead to FDA approvals, and 
FDA approvals would lead to revenues, for example.  Sixteen participants (18%) 
drew a network (spider web) model, where all NFM were connected to each other 
and to revenues.  It is important to note that with linear models and network 
models, there is a linkage between NFM and revenues, although the distance in 
terms of nodes/boxes would be greater in a linear model.  Six participants (7%) 
did not have NFM linked to revenues in the models that they drew.   
Analysis of “model drawn” by “links condition” indicates that 71% of 
participants who did not receive a causal links discussion drew a linear causal 
model, similar to the format illustrated in the links discussion.  Meanwhile, 80% 
of participants who received a causal links discussion drew a linear causal model, 
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similar to the format illustrated in the links discussion (which they had received 
previously).  Further breakdown by high and low familiarity participants indicates 
that, in the no links conditions, 77% of high familiarity participants drew a linear 
causal model, compared to 69% of low familiarity participants.  In the links 
conditions, 82% of high familiarity participants drew a linear causal model, 
compared to 79% of low familiarity participants.  These results suggest that the 
majority of investors possess a model similar to that provided by the company, 
and that high familiarity investors are even more likely to possess the linear 
model.  Additionally, it appears that slightly more low familiarity investors 
adopted a linear causal model after receiving the causal links discussion, although 
this increase is not statistically significant. 
The other analysis in this section involves comparing the causal models 
drawn to the judgments made by investors.  Given that 93% of participants linked 
a non-financial measure to revenues, there is not enough variation in the “linked 
or not” condition to analyze subsequent participant judgments.  Where there is 
variation is in the number of nodes between FDA approval and revenues.  Recall 
that the majority of participants drew linear causal models where nodes were 
connected sequentially.  Depending on what nodes were used, FDA approvals, 
while ultimately linked to revenues, could be directly linked to revenues, or could 
be 2 (or 3 or more) nodes removed.  In the case of FDA approvals, forty-seven 
participants drew a direct link between FDA approval and revenues, while 
twenty-one participants connected FDA approval and revenues, but though an 
intermediate node (the most common ones being product formulation or future 
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financial performance).  If the existence of an intermediate node between FDA 
approval and revenues reflects a perceived lagged effect of FDA approval on 
revenues, then estimates of next year revenue and revenue growth should be more 
differentiated (HI NFM vs. LO NFM) when there are fewer intermediate nodes.   
I performed a 2X2 ANOVA with number of intermediate nodes and NFM 
performance as the independent variables.  When revenue growth is used as the 
dependent variable, there is a significant nodes by NFM performance interaction 
(F=3.197, p=.04, one-tailed), consistent with predictions. There is also a main 
effect for NFM performance.  When next year revenue is used as the dependent 
variable, there is no significant interaction, and there are no main effects for nodes 
or NFM performance.  There was similar variation on the number of intermediate 
nodes between FDA application and revenues.  I performed a 2x3 ANOVA, with 
three levels of numbers of nodes and two levels of NFM performance, with no 
significant interaction or main effects.  Overall, there appears to be slight support 
for the notion that there is an association between the causal model drawn and 
investor judgments, although this association could depend greatly on the context 
and setting.  
5.7  SECOND-ORDER JUDGMENTS 
In a recent study, Botosan (1997) documents a relationship between the 
quantity of voluntary disclosure and cost of capital.  The relationship is consistent 
with the notion that increased disclosure reduces uncertainty, leading to lower 
cost of capital.  In this section, I provide results of exploratory analysis that 
examines whether expanded disclosure of non-financial intangibles information 
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(with and without supplemental links disclosure) affects second-order judgments 
(confidence, variance), which are presumably tied to cost of capital. 
Recall that participants were asked to indicate the level of confidence that 
they had in their point forecasts of next year net income and next year revenue.  
Confidence judgments were compared across the three disclosure conditions (No 
NFM, NFM no links, and NFM links).  For the full sample, a one-way ANOVA 
indicates no significant differences in net income confidence judgments across the 
three conditions (F=.290, p=.75) and no significant differences in revenue 
confidence judgments across the three conditions (F=.332, p=.72).  Confidence 
judgments were also compared using two-way ANOVA.  For the full sample, 
there are no significant main effects or interactions for links discussion or level of 
NFM performance (highest F=1.088, lowest p-value is .30) 
For the low familiarity subset, a one-way ANOVA indicates no significant 
differences in net income confidence judgments (F=.172, p=.84) or revenue 
confidence judgments (F=.348, p=.71) across the three disclosure conditions.  
Confidence judgments were also compared using a two-way ANOVA.  For 
revenue confidence judgments, there are no significant main effects or 
interactions for links discussion or level of NFM performance (highest F=.485, 
lowest p-value=.49).  For net income confidence judgments, there is a significant 
links by performance interaction (F=4.469, p=.04), where confidence judgments 
become more extreme when links are provided (the main effect for links is not 
significant, however, F=.138, p=.71).  Confidence is highest when causal links are 
provided and non-financial performance is low (mean=5.90, on an 11-point Likert 
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scale, ranging from 0 to 10) while confidence is lowest when causal links are 
provided and non-financial performance is high (mean=4.08).  This result was not 
predicted.  Overall, the results looking at confidence judgments do not support the 
conjecture that increased disclosure with causal links discussion leads to increased 
investor confidence. 
Confidence was also measured by asking participants to provide optimistic 
and pessimistic predictions for next year net income and next year revenue.  
Participants were told that these optimistic and pessimistic predictions should 
correspond to the upper and lower bounds, respectively, of a 95% confidence 
interval.  If expanded disclosures of non-financial measures and causal links 
discussion lead to reduced uncertainty, this should be reflected in the width of 
participants’ confidence intervals.  Results for the full sample indicate that there 
are no significant differences in net income confidence intervals (F=.344, p=.71) 
or revenue confidence intervals (F=1.858, p=.16) across the three disclosure 
conditions.  Confidence intervals were also compared using two-way ANOVA.  
For net income confidence intervals, there are no significant main effects or 
interactions for links discussion or level of NFM performance (highest F=.538, 
lowest p-value=.47).  For revenue confidence intervals, there is a significant main 
effect for links (F=4.227, p=.04).  However, confidence intervals are larger when 
links are provided (mean = $68.2 million) than when they are not provided (mean 
= $53.8 million), contrary to expectations.   
For the low familiarity subset, there are no significant differences in net 
income confidence intervals (F=.827, p=.44) or revenue confidence intervals 
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(F=1.425, p=.25) across the three disclosure conditions.  Confidence intervals 
were also compared using two-way ANOVA.  For net income and revenue 
confidence intervals, there are no significant main effects or interactions for links 
discussion or level of NFM performance (highest F=1.966, lowest p-value=.17).  
Overall, the results looking at confidence intervals do not support the conjecture 
that increased disclosure of non-financial measures with causal links discussion 
leads to increased investor confidence, through reduced uncertainty. 
The variance of investors’ next year revenue and revenue growth 
judgments was also examined.  If expanded disclosure reduces uncertainty, this 
should be reflected in lower variance of investor judgments when causal links are 
provided.  I computed Levene’s statistic for these judgments for the full sample, 
and found no significant differences in the variance of participants’ next year 
revenue judgments across conditions.  There is a significant difference in the 
variance of participants’ revenue growth judgments (Levene statistic=5.458, 
p=.01).  However, the higher variance is related to the level of NFM performance 
(low performance, higher variance), and is not related to the disclosure condition, 
again contrary to expectations. 
Overall the results in this study looking at self-reported confidence, 
confidence intervals, and variance of judgments do not support the notion that 
expanded disclosure of non-financial intangibles information increases investor 
confidence, even when the information is accompanied by supplemental cause-
and-effect links information.  One possible explanation for these results is the 
presence of offsetting effects.  On one hand, disclosures of NFM performance 
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should reduce uncertainty on the part of the investor in this setting, leading to 
increased confidence.  On the other hand, these disclosures could also highlight 
the complexities of forecasting future performance for an R&D intensive 
company, in terms of the multitude of inputs to be considered and the complex 
translation of these inputs into judgments of future financial performance.  If 
investors learn from these disclosures that they actually know very little, this will 
lead to reduced confidence. 
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Chapter 6: Summary and Conclusions 
In this study, I examine in an experimental setting whether and when 
expanded disclosures of intangibles information influence investor performance 
evaluations.  To this end, I introduce a progression of intangibles disclosures, 
from disclosures of financial information only to disclosures of non-financial 
intangibles information to disclosures of non-financial information with a causal 
links discussion added.  The central prediction in this study is that investors are 
less likely to use non-financial intangibles information and will not differentiate 
between above-average and below-average firms, in the absence of disclosure of 
cause-and-effect linkages.  Once links are provided, they are hypothesized to 
facilitate retention and use/weighting of non-financial intangibles information and 
lead to investors making more differentiated evaluations of firms with above and 
below-average performance on non-financial measures.  Because judgments 
involving NFM involve lagged effects, a well-developed causal model plays a 
role in how and whether NFM are used in subsequent investor judgments, because 
causally linked information is more likely to be reflected in subsequent related 
judgments.  The choice of links discussion as an independent variable in this 
study is inspired by the managerial accounting literature.  Just as the provision of 
links via the Balanced Scorecard is hypothesized to lead to increased emphasis by 
managers on linked non-financial measures in a managerial accounting setting 
and increased understanding, the provision of causal links in this setting is 
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expected to lead to increased use of non-financial intangibles disclosures in 
investor judgments, especially those with low familiarity with the industry.  
For the full sample of study participants, I find mixed results, depending 
on whether next year revenue or revenue growth (3 to 5 years out) is used as the 
dependent variable.  Results are stronger and more consistent with hypotheses 
when data were analyzed for the subset of participants who self-reported low 
familiarity with the pharmaceutical setting.  These results suggest that disclosure 
alone of non-financial intangibles information may not be sufficient to influence 
low familiarity investors’ performance judgments and that these investors need 
causal links information to process and incorporate non-financial measures in 
their judgments.  Additionally, the results suggest that having causal models about 
non-financial measures and their relationships with future financial performance 
measures helps to counteract the complex relationships between non-financial 
measures and future financial performance, and investors can either possess 
models based on prior work experience and schooling (antedecents of 
“knowledge” in the Libby and Lift, 1993, model) or can acquire it from 
supplemental links discussion (“environment” in the Libby and Luft, 1993, 
model).   
Financial reporting continues to come under scrutiny for its perceived 
deficiencies in capturing and communicating firm value.  With intangible assets 
getting the credit (or the blame) for being the biggest source of the disconnect 
between GAAP financial statements and firm value, firms have been encouraged 
to close the gap and get their message out to investors by expanding disclosures of 
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intangibles information.  This study weighs in on this issue by providing evidence 
on the effect on investor judgments from providing expanded intangibles 
disclosures, and the necessary conditions for any anticipated benefits to be 
achieved.  Consequently, this study is of interest to managers of firms (especially 
those of intangible-heavy firms), accounting researchers, and standard setters. 
One of the limitations of this study is its context.  The hypothetical 
company in the study is a pharmaceutical firm with products already in the market 
(so it is profitable), while also having products in the pipeline.  This context was 
chosen because it is the prototypical inter-temporal intangibles situation: R&D 
expenditures are incurred upfront, and cash and earnings payoffs occur in 
subsequent years.  Additionally, intangible assets related to R&D expenditures are 
the types of intangible assets covered by the FASB’s project on disclosures of 
information about intangible assets.  On the other hand, the AAA FASC (AAA 
FASB, 2003) observes that the R&D context is unique among intangibles, 
because of existing disclosure rules, which may limit the generalizability of this 
study to other complex intangibles relationships.  Future research could examine 
expanded disclosures of intangibles information in other intangible asset contexts, 
such as those related to customer or employee satisfaction or distribution 
channels.  Other areas for future research include examining the specific 
proposals (historical cost and fair value) being considered by the FASB, 
examining the effect of expanded intangibles disclosures when the credibility of 
the discloser is varied, and examining the effect of standardization and increased 
comparability of intangibles information on investor judgments. 
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Another area for future research is the examination of investors’ causal 
models and their processing of across-period financial and non-financial 
information.  Because the R&D investment/pharmaceutical company setting in 
this study was so well-known, a majority of investors already possessed a causal 
model similar to the one disclosed by the company.  Future research could 
examine settings with more obscure non-financial-financial relationships, where 
the ex ante causal models held by investors are either more varied/divergent or 
non-existent.  Such research could examine the effect of having a causal model on 
investors’ reactions to disclosed information and could examine whether 
company-disclosed causal links discussion is effective in altering investors’ ex 
ante causal models. 
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Thank you for participating in this study.  The purpose of the study is to 
investigate how investors make judgments and decisions.  Because this 
study involves decisions in the field of accounting, graduate business 
students at the University of Texas at Austin were selected to participate 
in this study.  Your participation should take approximately 20 minutes. 
 
For purposes of this study, you are asked to assume the role of an 
investor evaluating the common stock of a company.  Assume that you 
manage your own investments and you are considering adding the 
common stock of Panax Pharmaceuticals, Inc. to your investment 
portfolio. 
 
In this study, you will be provided with the following information about 
Panax Pharmaceuticals, Inc.: background information about the company 
(PART A), and a press release, containing selected financial and non-
financial information about the company (PART B). 
 
After reading and reviewing this information, you will be asked to make 
several judgments (PARTS C and D).  Your individual responses in this 
study will remain strictly confidential and will only be analyzed after 
being combined with the response of other participants.   
 
The case information you will receive is not intended to include all the 
information that would potentially be available if you were evaluating 
the common stock of Panax Pharmaceuticals, Inc.  However, for 
purposes of this study, base your judgments on the information provided. 
 
Should you have any questions during this study, please do not hesitate 
to ask me those questions.  Please do not talk to others about the study 
during your participation in it.  Thank you again for your participation.  
 
 
Alex C. Yen 
Ph.D. Student in Accounting 




*Supervising Professor: D. Eric Hirst (471-5565) 
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Panax Pharmaceuticals, Inc. (PART A) 
Company Background 
Panax Pharmaceuticals, Inc. (the Company) is a biopharmaceutical company 
engaged in the discovery, development, manufacturing, and marketing of 
prescription pharmaceutical products, principally for the cardiovascular and 
respiratory markets.  Panax currently has two commercially available products, 
Chol-arrest ® and HDL Builder ®.  Chol-arrest ® is marketed as a treatment to 
reduce elevated low-density, lipoprotein cholesterol, commonly referred to as 
LDL or “bad cholesterol.”  HDL Builder ® is marketed as a treatment to increase 
high-density, lipoprotein cholesterol, commonly referred to as HDL or “good 
cholesterol.”  Panax also has a number of projects in its research and development 
pipeline.   
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[Links discussion manipulation (this page and the following 2 pages) – 
depending on the condition to which they are assigned, participants either 
receive the 3 page links discussion or not] 
PANAX PHARMACEUTICALS, INC. 
 
Research and Development Strategy 
(excerpt from Management’s Discussion and Analysis filed with the 2002 Form 
10-K) 
 
A key element of the Company’s strategy to increase shareholder value is the investment 
in research and development activities, in order to innovate and bring new products to the 
marketplace.  This process is illustrated in the diagram on the following page. 
Through investment in research and development, the Company identifies potential new 
products and develops them.  This is followed by product testing in clinical trials.  If 
successful in the clinical trial stage, the Company files a New Drug Application with the 
Food and Drug Administration.  Once approved by the FDA, the product is moved to 
commercial production, where it will have a positive impact on the Company’s revenues 
in subsequent years.    
The impact of R&D investment on future financial performance (revenues from product 
sales) is a function of the amount invested, success at developing products, success at 
obtaining FDA approvals, and the speed at which products can be pushed through the 
pipeline.   
Accordingly, non-financial measures such as: 
•  the number of projects in the pipeline 
•  FDA approvals, and  
•  time to completion of new products  
are important predictors of the Company’s future financial performance (i.e. future 
revenues from product sales and future net income), as products in the pipeline, once 




























































   
   








































   
   



























   
   
   
 
   
   
























   








































































































































































































































































































































































































































































































































































PRESS RELEASE (PART B) 
(Assume that it is February 2003 and the following press release regarding 2002 results 
was issued earlier today by Panax.) 
 
PANAX ANNOUNCES ANNUAL RESULTS 
 
Revenues increase 18% 
Net Income up 1% 
 
Dateline:  Philadelphia, PA, February 10, 2003 
  
Text: Panax Pharmaceuticals, Inc. today reported results for the year ended December 
31, 2002.  Revenue for the year ended December 31, 2002 was $161.2 million, an 18% 
increase from revenue of $136.3 million in calendar 2001. 
The Company reported net income of $37.5 million for the year ended December 31, 
2002, as compared to net income of $37.0 million in 2001.  Net income was relatively 
flat in 2002 as compared to 2001, despite the Company’s sales growth, due to a 
significant increase in the Company’s Research and development expense, from $35.5 
million in 2001 to $52.0 million in 2002, an increase of 47%.  Research and development 
expense represents amounts incurred by the Company to develop new products and to 
expand its product line.  Under generally accepted accounting principles, such amounts 
are required to be expensed in the period incurred, leading to decreased net income in 
periods of high R&D investment.  
 
SUMMARIZED FINANCIAL HIGHLIGHTS (in thousands): 
 
     Year ended December 31,  
                                                                      2002                  2001        % Change 
 
Product sales $161,210 $136,338 18%  
Research and development expense $51,959 $35,461 47% 
Operating income before income taxes $58,613 $57,782 1% 




PRESS RELEASE (CONTINUED) 
 
PANAX PHARMACEUTICALS, INC. 
CONSOLIDATED STATEMENTS OF OPERATIONS 
(In thousands except per share data) 
                                                 Years Ended December 31, 
                                                     2002        2001 
Revenues:  
 
Product sales                                     $161,210    $136,338 
 
Operating costs and expenses: 
 
Cost of sales                                       14,781      12,770   
Research and development expense*                   51,959      35,461 
Selling, general and administrative expense         35,857      30,325 
 
      Total operating costs and expenses           102,597      78,556 
 
Operating income before income taxes                58,613      57,782 
  
Provision for income taxes                          21,101      20,802 
 
Net income                                         $37,512     $36,980   
*EXCERPT FROM “Note 1. Summary Of Significant Accounting Policies”: Research and 
Development -- Research and development costs are expensed as incurred. 
 
 
PANAX PHARMACEUTICALS, INC. 
CONDENSED CONSOLIDATED BALANCE SHEETS 
(In thousands) 
                                                       December 31 
                                                    2002          2001 
Assets 
 
Total current assets                               308,954       280,867 
 
Property, plant and equipment, net                 144,178       131,071 
 
Other assets                                       113,283       102,984 
 
Total assets                                   $   566,415   $   514,922 
  
Liabilities and Shareholders' Equity 
 
Total current liabilities                          144,052       128,199 
 
Notes payable                                      130,157       132,029 
 
Total shareholders' equity                         292,206       254,694 
Total liabilities and shareholders' equity     $   566,415   $   514.922 
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(Level of Non-Financial Performance Manipulation) 
 
PRESS RELEASE (CONTINUED) 
 
PANAX PHARMACEUTICALS, INC. – REPORT ON NON-FINANCIAL MEASURES 
AS OF DECEMBER 31, 2002 
 
                           HI(LO)   INDUSTRY 
Measure                      PANAX   AVERAGE 
 
 
Employee training programs offered     8  10 
 
Expected FDA Approvals of New Products in 2003   3 (1) 2 
 
Foreign patent applications as a percentage of 
total patent applications     50%  40% 
 
Number of awards for family-friendly  
workplace (2002)       1  2 
 
Number of projects currently 
   in the development pipeline (12/31/02)    6 (2) 4 
 
Social justice rating       85  75     
 
Time to completion of new products     3 (7)yrs 5 yrs 
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PART C – QUESTIONS 
 
•   PLEASE ANSWER THE FOLLOWING QUESTIONS IN THE ORDER THEY ARE 
PRESENTED. 
• YOU ARE FREE TO LOOK BACK AT PARTS A&B OF THE CASE MATERIALS 
WHEN ANSWERING THESE QUESTIONS. 
• AFTER YOU HAVE ANSWERED A QUESTION, PLEASE DO NOT GO BACK AND 
CHANGE YOUR RESPONSE. 
 
 
1. Based on all of the information provided to me in the case, I predict Panax’s net 
income to be ______________ (in thousands) for next year (calendar year 2003). 
                                Write in a number  
 
 
2. I am _______________ of the accuracy of my net income forecast provided above 
(please indicate your answer by marking an “X” on the scale below). 
 
 
          
          
 0   1   2  3  4  5  6  7  8  9         10 
Not at all 
Confident         
              Completely 
              Confident 
 
 
3. In addition to providing your best estimate of 2003 net income (in question 1), please 
also provide an optimistic prediction and a pessimistic prediction for 2003 net 
income.  The optimistic and pessimistic forecast would represent the upper and lower 
bounds of a 95% confidence interval, respectively.  
 
Based on all of the information provided to me in the case, I am 95% certain that 
Panax’s net income for next year will be BETWEEN: 
 
   _____________ (in thousands) (Pessimistic prediction/Lower bound) 
   Write in a number 
    
   AND 
 
   _____________ (in thousands) (Optimistic prediction/Upper bound) 






4. Please explain how you arrived at your net income prediction (i.e. what information 
did you consider?). 
      __________________________________________________________________ 
      __________________________________________________________________ 
      __________________________________________________________________ 
      __________________________________________________________________ 
      __________________________________________________________________ 
      __________________________________________________________________ 
      __________________________________________________________________ 
 
      __________________________________________________________________ 
 
5. Based on all of the information provided to me in the case, I predict Panax’s 
revenues from product sales to be ______________ (in thousands) for next year 
(calendar year 2003).                          Write in a number 
 
6. I am _______________ of the accuracy of my revenue forecast provided above 
(please indicate your answer by marking an “X” on the scale below). 
 
          
          
 0   1   2  3  4  5  6  7  8  9         10 
Not at all 
Confident         
              Completely 
              Confident 
 
7. In addition to providing your best estimate of 2003 revenues (in question 5), please 
also provide an optimistic prediction and a pessimistic prediction for 2003 revenues.  
The optimistic and pessimistic forecast would represent the upper and lower bounds 
of a 95% confidence interval, respectively.  
 
Based on all of the information provided to me in the case, I am 95% certain that 
Panax’s revenues for next year will be BETWEEN: 
 
 
   _____________ (in thousands) (Pessimistic prediction/Lower bound) 
   Write in a number 
    
   AND 
 
   _____________ (in thousands) (Optimistic prediction/Upper bound) 
                                   Write in a number           
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8. I believe that Panax’s potential for future net income growth (in the next 3 to 5 
years) is ___________. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Very 
Weak 




9. I believe that Panax’s potential for future revenue growth (in the next 3 to 5 years) 
is ___________. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Very 
Weak 
            Very  
Strong 
10. I believe that Panax’s overall financial condition (strength of the balance sheet in 
terms of liquidity and risk) is ____________________. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Very 
Poor 
            Very  
Good 
11. I believe that Panax’s management is ____________________. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at all 
Competent 
            Very 
         Competent 
12. I believe that Panax’s management is doing a(n) _________________ job in its 
stewardship of the company. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Very 
Weak 
            Outstanding/ 
Excellent 
 
13. I believe that Panax’s low growth in net income for 2002 (despite revenue growth) 
can be attributed _______________ to the accounting rules concerning R&D 
expenditures.   
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at 
All 
            In Large  
Part  
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14. I believe that Panax’s low growth in net income for 2002 (despite revenue growth) 
can be attributed _______________ to overall economic conditions. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at 
All 
            In Large 
Part 
 
15. I believe that Panax’s low growth in net income for 2002 (despite revenue growth) 
can be attributed _______________ to the timing of benefits from its R&D 
investments.  
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at 
All 
            In Large 
Part  
 
16. I believe that Panax’s low growth in net income for 2002 (despite revenue growth) 
can be attributed _______________ to the quality of its management team.  
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at 
All 
            In Large 
Part 
 
17. I found the disclosure of R&D expense in the income statement to be ____________ 
useful in deriving my net income estimate for 2003. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at  
All 
            Extremely  
 
 
18. I found the information in the report on non-financial measures to be 
____________ useful in deriving my net income estimate for 2003. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at 
All 
            Extremely  
 
19. I can ___________ determine how actions undertaken by management in the 
current year were intended to lead to outcomes in future periods. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at  
All 




20. I believe that Panax’s disclosures of its non-financial measures were __________ 
credible. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Not at  
All 
            Completely 
21. For Panax, I believe that Net income (under GAAP) is a ______________ measure 
for assessing a company’s performance. 
 
              
              
 1  2  3  4  5  6  7  8  9  10  11  12  13  14    15 
Very 
Poor 




YOU HAVE NOW COMPLETED PART C.  PLEASE PLACE THE MATERIALS 
YOU HAVE JUST COMPLETED (PARTS A, B, and C) IN THE MANILA 
ENVELOPE. 
 
YOU MAY NOW CONTINUE ON TO PART D. 
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PART D-PLEASE DO NOT LOOK BACK AT THE CASE MATERIALS 
WHEN ANSWERING THE FOLLOWING QUESTIONS. 
 
1. The number of projects currently in Panax’s development pipeline is (circle one 
answer):  
0       1        2       3       4       5       6       7       8       9      10     >10 
 
2. The number of projects currently in Panax’s development pipeline is (circle one 
answer): 
 (higher than) the industry average 
 (the same as) the industry average 
 (lower than) the industry average 
 
3. The average number of years that it takes Panax to complete the cycle from 
initial investment to development is: 
 
0       1        2       3       4       5       6       7       8       9      10     >10 
 
4. Did you receive a discussion of the Company’s research and development 
strategy and procedure, as part of the company background in part A (circle one 
answer)  YES    NO.   
 87 
5. Draw arrows between the boxes below to indicate how Panax’s actions, non-
financial measures, and future financial outcomes are connected (draw as many 
arrows as necessary). 
 
  
 Investment in R&D  
       FDA Application 
   
          
        Clinical Trials 
Shareholder Value 
     Revenue         
  
          




 Future Financial Performance 
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IN ORDER TO HELP US BETTER UNDERSTAND WHY YOUR RESPONSES MIGHT 
DIFFER FROM THOSE OF YOUR COLLEAGUES, PLEASE ANSWER THE FOLLOWING 
QUESTIONS.  
1.  Have you ever made investments in the common stock of a company?YES     NO 
  If yes, approximately how many times? ___________ times 
2.  Do you plan to invest in the common stock of a company at some time in the future?   
  YES  NO 
3.  Have you ever made investments in a common stock mutual fund?     YES NO 
4.  Prior to this study, had you ever read the financial statements and accompanying 
footnotes section of an annual report?                 YES        NO  
5.  What is your gender?      F        M 
6.  Please indicate your years of work experience in any of the following fields: 
 ______ Investment banking  _____  Public Accounting 
 ______ Retail    _____  High Tech 
 ______ Consumer Goods Mftg  _____  Education 
 ______ Commercial Bank/Insurance _____  Pharmaceuticals 
 ______ Medical/Dental   _____  Gov’t (incl. Military) 
 ______ Hospitality   _____  Energy 
 ______ Natural Sciences  _____  Other 
7. Please indicate your level of familiarity with the pharmaceutical industry, based on 
prior work experience, school projects, etc. (1=not familiar at all, 7=very familiar) 
                   1        2        3        4        5        6        7 
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8. How many Accounting courses have you taken (including those you are taking this 
semester)?             ___________ courses 
 
9. How many Finance courses have you taken (including those you are taking this 
semester)?             ___________ courses 
 
 
YOU ARE FINISHED WITH THE CASE. 




  TO ENTER INTO THE DRAWING, PLEASE THE DETACH THE PIECE OF PAPER 
BELOW AND WRITE YOUR NAME ON IT.  THEN, PLACE THIS PART OF THE 
QUESTIONNAIRE INTO THE MANILA ENVELOPE WITH ALL THE OTHER CASE 
MATERIALS.  WHEN YOU TURN IN THE ENVELOPE, PLACE YOUR NAME INTO 
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